American Society of Clinical Oncology Virtual Scientific Program 2020
Format:1326 videos + 417 pdfs, size: 574 GB
Course Audience: oncologist
[OPTIMAL 3] A phase III trial to evaluate the efficacy and safety of DHP107 (Liporaxel, oral paclitaxel) compared to Taxol (Video MP4 Format)
12-chemokine gene expression score in breast cancer patients treated with neoadjuvant chemotherapy (Video MP4 Format)17-year incidence trends of anal squamous cell carcinoma (Video MP4 Format)4-miRNA signature combined with MGMT methylation status in glioblastoma (Video MP4 Format)4R Program results in breast cancer the impact of 4R Care Delivery Model on timing and sequence of guideline (Video MP4 Format)A comparison of patients’ and physicians’ expectations regarding precision oncology tests (Video MP4 Format)A comprehensive analysis of the demographics and citation-based productivity of radiation oncologists practici (Video MP4 Format)A Deep Dive Into Preoperative HER2 Biomarkers (Video MP4 Format)A Deep Dive Into Preoperative HER2 Biomarkers (PDF Format)A first-in-class ex vivo combination between cytokine-induced memory like (CIML) NK cells and a CD38 targeting antibody (Video MP4 Format)A geriatric assessment (GA) intervention to reduce treatment toxicity in older patients with advanced cancer (Video MP4 Format)A geriatric assessment (GA) intervention to reduce treatment toxicity in older patients with advanced cancer (PDF Format)A highly effective and practical desensitization regimen Results in comparable clinical outcomes for multiple myeloma patients (Video MP4 Format)A Ib II study of the combination of lenvatinib (L) and eribulin (E) in advanced liposarcoma (LPS) and leiomyosarcoma (LMS) (LEADER) (Video MP4 Format)A Ib II study of the combination of lenvatinib (L) and eribulin (E) in advanced liposarcoma (LPS) and leiomyosarcoma (LMS) (LEADER) (PDF Format)A mid-chemoradiation dynamic risk model integrating tumor features and ctDNA analysis for lung cancer outcome prediction (Video MP4 Format)A model comparing the value of broad next-gen sequencing (NGS)-based testing to single gene testing (SGT) (PDF Format)A multicenter phase Ib II study of DNA-PK inhibitor peposertib (M3814) in combination with capecitabine (Video MP4 Format)A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome (Video MP4 Format)A multicenter phase II study of venetoclax plus dose-adjusted R-EPOCH (VR-EPOCH) for Richter’s syndrome (PDF Format)A multicenter study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis (Video MP4 Format)A multicenter study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis (PDF Format)A multicenter, randomized, controlled phase II study Efficacy and safety of PSMA-targeted radioligand therapy I-131-1095 (1095) (Video MP4 Format)A multiparameter classifier to predict response to lapatinib plus trastuzumab (LT) without chemotherapy in HER2+ (Video MP4 Format)A multiparameter classifier to predict response to lapatinib plus trastuzumab (LT) without chemotherapy in HER2+ (PDF Format)A multi-stakeholder platform to prospectively link longitudinal real-world clinico-genomic, imaging, and outcomes data (Video MP4 Format)A new prognostic and predictive tool to enhance shared decision making in stage III colon cancer (Video MP4 Format)A New Wave of Vaccine Strategies Making Progress (Video MP4 Format)A New Wave of Vaccine Strategies Making Progress (PDF Format)A novel biosignature to assess residual risk in ductal carcinoma in situ (DCIS) patients after standard treatment (Video MP4 Format)A pediatric and young adult phase I dose escalation study of BXQ-350 for solid and central nervous system tumors (Video MP4 Format)A pilot study evaluating the safety, tolerability, and efficacy of doxorubicin and pembrolizumab in patients (Video MP4 Format)A pilot study of a wearable monitoring system as an adjunct to geriatric assessment in older adults with cancer (Video MP4 Format)A pilot study of Bruton’s tyrosine kinase inhibitor ibrutinib alone and in combination with PD-1 inhibitor (Video MP4 Format)A prospective analysis of chemotherapy-induced nausea and vomiting in gastrointestinal cancers (Video MP4 Format)A prospective phase I trial of dendritic cell-based cryoimmunotherapy in metastatic castration-resistant prostate cancer (Video MP4 Format)A prospective phase II open-label randomized controlled trial to compare mandibular preservation in upfront (Video MP4 Format)A prospective validation cohort study of baseline plasma cell-free DNA (cfDNA) as a prognostic biomarker (Video MP4 Format)A prospective validation cohort study of baseline plasma cell-free DNA (cfDNA) as a prognostic biomarker (PDF Format)A proteomic biomarker discovery platform for predicting clinical benefit of immunotherapy in advanced melanoma (Video MP4 Format)A phase I clinical trial on intratumoral and intracavitary administration of ipilimumab and nivolumab in patients (Video MP4 Format)A phase I combination study of GMCSF bi-shRNA(furin) DNA-transfected autologous tumor immunotherapy (Video MP4 Format)A phase I dose escalation and expansion study of the next generation oral SERD AZD9833 in women with ER-positive (Video MP4 Format)A phase I dose escalation study evaluating the safety and tolerability of a novel anti-HER2 antibody-drug conjugate (Video MP4 Format)A phase I dose-escalation and expansion study of intratumoral CV8102 as single-agent or in combination (Video MP4 Format)A phase I II clinical trial of autologous CMV-specific T cells in glioblastoma (GBM) patients to reveal a lack of immune (Video MP4 Format)A phase I II study of GB1275, a first-in-class oral CD11b modulator, alone, and combined with pembrolizumab (Video MP4 Format)A phase I II study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors (Video MP4 Format)A phase I II study of PI3Kinase inhibition with copanlisib combined with the anti-PD-1 antibody nivolumab (Video MP4 Format)A phase I II study of REGN5093, a MET x MET bispecific antibody, in patients with MET-altered advanced (Video MP4 Format)A phase I II study of REGN5678 (Anti-PSMAxCD28, a costimulatory bispecific antibody) with cemiplimab (anti-PD-1) (Video MP4 Format)A phase I II study of rovalpituzumab tesirine in delta-like 3-expressing, advanced solid tumors (Video MP4 Format)A phase I II, two-part, multicenter, first-in-human study of DS-7300a in patients with advanced solid malignant tumors (Video MP4 Format)A phase I study of ALX148, a CD47 blocker, in combination with standard anticancer antibodies and chemotherapy (Video MP4 Format)A phase I study of CX-4945 administered orally twice daily to patients with advanced basal cell carcinoma (Video MP4 Format)A phase I study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23, and IL-36? (Video MP4 Format)A phase I study of nanoliposomal irinotecan and 5-fluorouracil folinic acid in combination with interleukin-1-alpha (Video MP4 Format)A phase I study of SHR6390, a cyclin-dependent kinase 4 6 inhibitor in patients with advanced breast cancer (ABC) (Video MP4 Format)A phase I trial targeting advanced or metastatic pancreatic cancer using a combination of standard chemotherapy (Video MP4 Format)A phase I, first-in-human, open-label, dose-escalation study of MGD013, a bispecific DART molecule binding PD-1 (Video MP4 Format)A phase I, first-in-human, open-label, dose-escalation study of MGD013, a bispecific DART molecule binding PD-1 (PDF Format)A phase I, first-in-human, open-label, dose-escalation, safety, pharmacokinetic, and pharmacodynamic study of oral (Video MP4 Format)A phase I, open-label, multicenter study to assess the safety, pharmacokinetics, and preliminary antitumor activity (Video MP4 Format)A phase Ia Ib, open-label first-in-human study of the safety, tolerability, and feasibility of gene-edited autologous (Video MP4 Format)A phase Ib II study of eribulin (ERI) plus pembrolizumab (PEMBRO) in metastatic triple-negative breast cancer (Video MP4 Format)A phase Ib II study of niraparib plus temozolomide plus atezolizumab versus atezolizumab as maintenance (Video MP4 Format)A phase Ib II study of olutasidenib in patients with relapsed refractory IDH1 mutant gliomas (Video MP4 Format)A phase Ib II study of olutasidenib in patients with relapsed refractory IDH1 mutant gliomas (PDF Format)A phase Ib II study of the polo-like kinase 1 (PLK1) inhibitor, onvansertib, in combination with FOLFIRI and bevacizumab (Video MP4 Format)A phase Ib II, multicenter, open-label study of DSP-7888 dosing emulsion in combination with immune checkpoint inhibitors (CPI) (Video MP4 Format)A phase Ib III randomized, double-blind, placebo-controlled study of tazemetostat plus doxorubicin as frontline therapy (Video MP4 Format)A phase Ib study of abemaciclib in combination with pembrolizumab for patients (pts) with stage IV Kirsten (Video MP4 Format)A phase Ib study of abemaciclib in combination with pembrolizumab for patients with hormone receptor positive (HR+) (Video MP4 Format)A phase Ib study of endogenous SLC45A2-specific cytotoxic T cells for the treatment of patients with metastatic uveal melanoma (Video MP4 Format)A phase Ib study of lenvatinib (LEN) plus pembrolizumab (PEMBRO) in unresectable hepatocellular carcinoma (uHCC) (Video MP4 Format)A phase Ib study of TQ-B2450 plus anlotinib in patients with advanced solid tumor (Video MP4 Format)A phase Ib study to evaluate the oral selective estrogen receptor degrader GDC-9545 alone or combined (Video MP4 Format)A phase Ib trial of enzalutamide with venetoclax in metastatic castration-resistant prostate cancer (mCRPC) (Video MP4 Format)A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) (Video MP4 Format)A phase Ib, open-label, dose-escalation trial of naptumomab estafenatox (Nap) in combination with durvalumab (MEDI4736) (Video MP4 Format)A phase II double-blind, randomized clinical trial assessing the tolerability of two different ratios of cannabis in patients (Video MP4 Format)A phase II III study of JZP-458 in patients with acute lymphoblastic leukemia (ALL) lymphoblastic lymphoma (LBL) (Video MP4 Format)A phase II multi-arm study of durvalumab and tremelimumab for advanced or metastatic sarcomas (PDF Format)A phase II open-label, multicenter, study to evaluate the efficacy and safety of rivoceranib in subjects with recurrent (Video MP4 Format)A phase II randomized study of telaglenastat, a glutaminase (GLS) inhibitor, versus placebo, in combination (Video MP4 Format)A phase II study evaluating atezolizumab (A), cobimetinib (C), and vemurafenib (V) in patients (pts) with BRAF-mutant melanoma (Video MP4 Format)A phase II study of anlotinib in treating patients with relapsed or metastatic primary malignant bone tumor (Video MP4 Format)A phase II study of M6620 in combination with carboplatin compared with docetaxel in combination (Video MP4 Format)A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced (Video MP4 Format)A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced (PDF Format)A phase II study of MT-3724, a novel CD20-targeting engineered toxin body, to evaluate safety, pharmacodynamics (Video MP4 Format)A phase II study of osimertinib for patients with radiotherapy-na‹ve CNS metastasis of non-small cell lung cancer (Video MP4 Format)A phase II study of rh-endostatin combined with paclitaxel and nedaplatin in treating patients with recurrent (Video MP4 Format)A phase II study of selective HDAC6 inhibition with KA2507 for second-line treatment of advanced biliary tract cancer (ABC-11) (Video MP4 Format)A phase II study on the efficacy and toxicity of cabozantinib in recurrent metastatic salivary gland cancer patients (Video MP4 Format)A phase II study to evaluate the need for two doses of nivolumab + ipilimumab combination (combo) immunotherapy (Video MP4 Format)A phase II study to evaluate the need for two doses of nivolumab + ipilimumab combination (combo) immunotherapy (PDF Format)A phase II trial of atezolizumab (anti-PD-L1) with carboplatin in patients with metastatic triple-negative breast cancer (Video MP4 Format)A phase II trial of cabozantinib in hormone receptor-positive breast cancer with bone metastases (Video MP4 Format)A phase II trial of nivolumab (NIVO) + palbociclib (PAL) + anastrozole (ANA) in postmenopausal women and men (Video MP4 Format)A phase II trial of PD-1 inhibition with INCMGA00012 in patients with previously treated unresectable or metastatic (Video MP4 Format)A phase II trial of preoperative FOLFIRINOX followed by gemcitabine-based chemoradiotherapy in patients (Video MP4 Format)A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma (Video MP4 Format)A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma (PDF Format)A phase II, multicenter study of encorafenib binimetinib followed by a rational triple-combination after progression in patients (Video MP4 Format)A phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing (Video MP4 Format)A phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing (PDF Format)A phase III randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) (Video MP4 Format)A phase III randomized trial of pleurectomy decortication plus chemotherapy with or without adjuvant hemithoracic (Video MP4 Format)A phase III randomized, double-blind placebo controlled study of armodafinil (Nuvigil) to reduce cancer-related fatigue (Video MP4 Format)A phase III randomized, double-blind placebo controlled study of armodafinil (Nuvigil) to reduce cancer-related fatigue (PDF Format)A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based (Video MP4 Format)A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based (PDF Format)A phase III study of venetoclax plus low-dose cytarabine in previously untreated older patients with acute myeloid leukemia (VIALE-C) (Video MP4 Format)A phase III trial of capivasertib and paclitaxel in first-line treatment of patients with metastatic triple-negative breast cancer (Video MP4 Format)A phase III trial of docetaxel versus docetaxel and radium-223 (Ra-223) in patients with metastatic (Video MP4 Format)A phase III trial of nivolumab with neoadjuvant chemotherapy and adjuvant endocrine therapy in ER+ HER2- primary (Video MP4 Format)A phase III, randomized, double-blind study of adjuvant cemiplimab versus placebo post-surgery and radiation therapy (RT) in patients (pts) (Video MP4 Format)A phase III, randomized, multicenter, open-label study of venetoclax or pomalidomide in combination with dexamethasone (Video MP4 Format)A phase III, randomized, placebo-controlled trial of nivolumab or nivolumab plus ipilimumab in patients (Video MP4 Format)A randomized controlled trial (RCT) testing a mobile application (app) to identify cancer treatment-related financial assistance (Video MP4 Format)A randomized controlled trial of a self-administered, online decision-aid (‘Navya Patient Preference Tool’) (Video MP4 Format)A randomized controlled trial of video-education or in-person genetic counseling for men with prostate cancer (Video MP4 Format)A randomized controlled trial of video-education or in-person genetic counseling for men with prostate cancer (PDF Format)A randomized phase I IIa study to evaluate the safety and efficacy of SNK01 (Video MP4 Format)A randomized phase II feasibility study of individualized stereotactic body radiation therapy (SBRT) versus transarterial (Video MP4 Format)A randomized phase II III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone for liver (Video MP4 Format)A randomized phase II III trial comparing hepatectomy followed by mFOLFOX6 with hepatectomy alone for liver (PDF Format)A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer (Video MP4 Format)A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer (PDF Format)A randomized phase II study of gemcitabine (G) alone or with pazopanib (P) in refractory soft tissue sarcoma (STS) (Video MP4 Format)A randomized phase II trial of secondary cytoreductive surgery (SCS) + – carboplatin hyperthermic intraperitoneal (Video MP4 Format)A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer SOC1 SGOG-OV2 (Video MP4 Format)A randomized phase III trial of secondary cytoreductive surgery in later recurrent ovarian cancer SOC1 SGOG-OV2 (PDF Format)A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women (Video MP4 Format)A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women (PDF Format)A randomized trial of a palliative care intervention for patients on phase I studies (Video MP4 Format)A randomized trial of a palliative care intervention for patients on phase I studies (PDF Format)A randomized, double-blind, phase II clinical trial of GI-6301 (yeast-brachyury vaccine) versus placebo in combination (Video MP4 Format)A sensitive and quantitative multimodal blood test for the detection of colorectal adenomas and cancer (Video MP4 Format)A signal-seeking trial of olaparib and durvalumab in homologous repair-deficient tumors (Video MP4 Format)A single-arm multicenter phase II trial of doxorubicin (Doxo) in combination with trabectedin (Trab) given as first-line (Video MP4 Format)A single-arm multicenter phase II trial of doxorubicin (Doxo) in combination with trabectedin (Trab) given as first-line (PDF Format)A single-institution and commercial laboratory database analysis of BRIP1-associated cancer risks (Video MP4 Format)A survey of cannabis use for symptom palliation in breast cancer patients by age and stage (Video MP4 Format)Abbreviated geriatric assessment (GA) in new oncology patients and its association with early death (Video MP4 Format)Acalabrutinib (Acala) versus idelalisib plus rituximab (IdR) or bendamustine plus rituximab (BR) in relapsed refractory (R R) (Video MP4 Format)Acalabrutinib in treatment-na‹ve chronic lymphocytic leukemia Mature results from phase II study demonstrating (Video MP4 Format)Accelerating New Agents in Slow-Growing Lymphomas (Video MP4 Format)Accelerating New Agents in Slow-Growing Lymphomas (PDF Format)Accuracy of 68Ga-PSMA-11 for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection (Video MP4 Format)Accuracy of 68Ga-PSMA-11 for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection (PDF Format)Acquired genomic alterations in circulating tumor DNA from patients receiving abemaciclib alone or in combination (Video MP4 Format)Activity and safety of larotrectinib in adult patients with TRK fusion cancer An expanded data set (Video MP4 Format)Activity of front-line window therapy with temozolomide plus irinotecan in patients with primary multifocal Ewing sarcoma (Video MP4 Format)Activity of front-line window therapy with temozolomide plus irinotecan in patients with primary multifocal Ewing sarcoma (PDF Format)Activity of SY-5609, an oral, noncovalent, potent, and selective CDK7 inhibitor, in preclinical models of colorectal cance (Video MP4 Format)ACUFOCIN Randomized clinical trial of ACUpuncture plus standard care versus standard care alone FOr Chemotherapy (Video MP4 Format)ACUFOCIN Randomized clinical trial of ACUpuncture plus standard care versus standard care alone FOr Chemotherapy (PDF Format)ADAPTcycle Adjuvant dynamic marker-adjusted personalized therapy (ADAPT) comparing endocrine therapy plus (Video MP4 Format)Adaptive dose optimization trial of stereotactic body radiation therapy (SBRT) with or without GC4419 (avasopasem manganese) (Video MP4 Format)Adding to Chemotherapy in Mesothelioma (Video MP4 Format)Adding to Chemotherapy in Mesothelioma (PDF Format)Adjuvant and Neoadjuvant Therapies in 2020 (Video MP4 Format)Adjuvant and Neoadjuvant Therapies in 2020 (PDF Format)Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy (Video MP4 Format)Adjuvant lenvatinib in combination with TACE for hepatocellular carcinoma patients with high risk of postoperative relapse (LANCE) (Video MP4 Format)Adjuvant Neoadjuvant Approaches What Works and What Doesn’t (Video MP4 Format)Adjuvant Neoadjuvant Approaches What Works and What Doesn’t (PDF Format)Adjuvant or neoadjuvant for nasopharynx That is the question (Video MP4 Format)Adjuvant Studies in Rare Populations (Video MP4 Format)Adjuvant Studies in Rare Populations (PDF Format)Adjuvant Therapy When Did It Get So Complex (Video MP4 Format)Adjuvant Therapy When Did It Get So Complex (PDF Format)Adoption of opportunistic salpingectomy for ovarian cancer prevention Results from a nationwide sample (Video MP4 Format)Adoptive T-Cell Therapies for Solid Tumors Square Peg, Round Hole (Video MP4 Format)Adoptive T-Cell Therapies for Solid Tumors Square Peg, Round Hole (PDF Format)Advanced Prostate Cancer Putting Survival Into Perspective (Video MP4 Format)Advanced Prostate Cancer Putting Survival Into Perspective (PDF Format)Advances in CAR-T From Hematologic to Solid Tumors (Video MP4 Format)Advances in Checkpoint Inhibition Through Toxicity and Drug Development Insights (Video MP4 Format)Advances in Checkpoint Inhibition Through Toxicity and Drug Development Insights (PDF Format)Affordable Care Act Medicaid expansion does not reduce guideline concordant cancer care disparities in vulnerable populations (Video MP4 Format)AGEN1181, a clinical stage Fc-engineered anti-CTLA-4 antibody with improved therapeutic potential for the treatment (Video MP4 Format)Algorithm for blood-based panel of methylated DNA and protein markers to detect early-stage hepatocellular (Video MP4 Format)ALL From the Tried and True to the Targeted and New (Video MP4 Format)Alliance A071401 Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations (Video MP4 Format)Alliance A071401 Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations (PDF Format)Alpelisib (ALP) + fulvestrant (FUL) in patients (pts) with PIK3CA-mutated (mut) hormone receptor-positive (HR+) (Video MP4 Format)Alpelisib (ALP) + fulvestrant (FUL) in patients (pts) with PIK3CA-mutated (mut) hormone receptor-positive (HR+) (PDF Format)ALTERNATE Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive (Video MP4 Format)ALTERNATE Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive (PDF Format)Alternative anti-CD20 antibody versus desensitization for lymphoma patients with drug hypersensitivity reactions (Video MP4 Format)Amivantamab (JNJ-61186372), an anti-EGFR-MET bispecific antibody, in patients with EGFR exon 20 insertion (exon20ins) (Video MP4 Format)Amyloidosis Don’t Suffer ‘The Runaways’ (Video MP4 Format)Amyloidosis Don’t Suffer ‘The Runaways’ (PDF Format)An automated EHR-based tool for identification of patients (pts) with metastatic disease to facilitate clinical trial (Video MP4 Format)An exploratory study of sorafenib plus toripalimab for unresectable hepatocellular carcinoma with portal vein tumor thrombus (Video MP4 Format)An independent review of arterial occlusive events (AOEs) in the ponatinib (PON) phase II PACE trial (NCT01207440) (Video MP4 Format)An open-label, multicenter, phase II study of ceritinib in patients with advanced ALK+ non-lung solid tumors (Video MP4 Format)Analysis of chemotherapy-related modulation of the immune microenvironment in muscle invasive bladder cancer (Video MP4 Format)Analysis of mutation detection of POLD1 pole in pan-cancer (Video MP4 Format)Analysis of treatment efficacy in the GEM-CESAR trial for high-risk smoldering multiple myeloma patients (Video MP4 Format)Analytical validation of digital cytometry (iSort) for leukocyte enumeration using stored blood (Video MP4 Format)Ancestry-specific gene expression profiles in TNBC tumors (PDF Format)Androgen Deprivation Too Little, Too Much, or Just Right (Video MP4 Format)Androgen Deprivation Too Little, Too Much, or Just Right (PDF Format)Annual trends in opioid prescribing for patients (Pts) with metastatic non-small cell lung cancer (mNSCLC) (Video MP4 Format)Anti-CTLA-4 probody BMS-986249 alone or in combination with nivolumab in patients with advanced cancers (Video MP4 Format)Antiemetic prophylaxis with NEPA Final results of the German AKYPRO study (Video MP4 Format)Anti-PD-1 in Less Common Skin Cancers (Video MP4 Format)Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma (Video MP4 Format)Apatinib as second-line therapy in Chinese patients with advanced hepatocellular carcinoma (PDF Format)Application of machine learning algorithms for the diagnosis of primary brain tumors (Video MP4 Format)Are symptoms distinguishable in ovarian cancer A nested case control study of insurance claims (Video MP4 Format)Are We Able to Move Beyond PD-L1 (Video MP4 Format)Are We Able to Move Beyond PD-L1 (PDF Format)ARISTOTLE A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation (Video MP4 Format)ASPEN Results of a phase III randomized trial of zanubrutinib versus ibrutinib for patients with Waldenstr”m macroglobulinemia (WM) (Video MP4 Format)ASPEN Results of a phase III randomized trial of zanubrutinib versus ibrutinib for patients with Waldenstr”m macroglobulinemia (WM) (PDF Format)Assessing impact of inpatient rotations on resident interest in hematology-oncology (Video MP4 Format)Assessing MRD in Multiple Myeloma Leave ‘No Doubt’ (Video MP4 Format)Assessing MRD in Multiple Myeloma Leave ‘No Doubt’ (PDF Format)Assessing the effect of immunosuppressive agents for immune-related adverse event management on tumor response (Video MP4 Format)Assessing the potential cost-effectiveness of the addition of atezolizumab to first-line platinum chemotherapy (Video MP4 Format)Assessment of FcgRIIIA single nucleotide polymorphisms (SNPs) on the efficacy of IgG1 monoclonal antibodies (mAbs) (Video MP4 Format)Association between complete response and survival in advanced melanoma treated with talimogene laherparepvec (T-VEC) plus ipilimumab (ipi) (Video MP4 Format)Association between immune and tumor gene signatures with response or resistance to tislelizumab monotherapy (Video MP4 Format)Association between Medicaid expansion status and metastatic disease at diagnosis in patients with melanoma (Video MP4 Format)Association of BRCA alteration (alt) type with real-world (RW) outcomes to PARP inhibitors (PARPi) in patients (pts) (Video MP4 Format)Association of chronotype and pain at baseline in ovarian cancer survivors participating in a lifestyle intervention (NRG GOG 0225) (Video MP4 Format)Association of detectable levels of circulating tumor DNA (ctDNA) with disease burden in prostate cancer (PC) (Video MP4 Format)Association of elevated red cell distribution width and overall survival in multiple myeloma (Video MP4 Format)Association of gene expression with clinical outcomes in patients with renal cell carcinoma treated with pembrolizumab in KEYNOTE-427 (Video MP4 Format)Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint (Video MP4 Format)Association of LRP1B pathogenic genomic alterations with favorable outcomes with immune checkpoint (PDF Format)Association of lymphocyte to monocyte ratio with clinical response and survival in patients with relapsed (Video MP4 Format)Association of medical comorbidities and cardiovascular disease with toxicity and survival in patients (Video MP4 Format)Association of neutrophil to lymphocyte ratio (NLR) with efficacy from JAVELIN Renal 101 (Video MP4 Format)Association of sarcopenia with higher toxicity and poor prognosis in nasopharyngeal carcinoma (Video MP4 Format)Associations between psoas muscle area (PMA) and density (PMD) with phase I oncology clinical trial outcomes (Video MP4 Format)Associations between psoas muscle area (PMA) and density (PMD) with phase I oncology clinical trial outcomes (PDF Format)AST-008 A novel approach to TLR9 agonism with PD-1 blockade for anti-PD-1 refractory Merkel cell carcinoma (MCC) (Video MP4 Format)Atezolizumab (atezo) therapy for locally advanced metastatic urinary tract carcinoma (mUTC) in patients (pts) (Video MP4 Format)Atezolizumab + obinutuzumab + venetoclax in patients with relapsed or refractory diffuse large B-cell Lymphomas (R R DLBCL) (Video MP4 Format)Atezolizumab combinations with targeted therapy for anaplastic thyroid carcinoma (ATC) (Video MP4 Format)ATM mutation carriers and family history of pancreatic cancer (Video MP4 Format)Autoantibodies as predictors for survival and immune-related adverse events in checkpoint inhibition (Video MP4 Format)Autoantibodies as predictors for survival and immune-related adverse events in checkpoint inhibition (PDF Format)Autoantibodies in Response and Toxicity (Video MP4 Format)Autologous stem cell transplantation for untreated transformed indolent B-cell lymphoma in first remission (Video MP4 Format)Avelumab in patients with gestational trophoblastic tumors resistant to monochemotherapy (Video MP4 Format)Avelumab in patients with gestational trophoblastic tumors resistant to monochemotherapy (PDF Format)AVID200, first-in-class TGF-beta 1 and 3 selective and potent inhibitor Safety and biomarker results of a phase I (Video MP4 Format)Axitinib plus pembrolizumab in patients with advanced renal cell carcinoma Long-term efficacy and safety from a phase Ib study (Video MP4 Format)Balancing Access, Value, and Quality of Care! (Video MP4 Format)Balancing Access, Value, and Quality of Care! (PDF Format)Balancing Risk and Benefit in Metastatic Colorectal Cancer (Video MP4 Format)BARCODE 1 A pilot study investigating the use of genetic profiling to identify men in the general population (Video MP4 Format)BARCODE 1 A pilot study investigating the use of genetic profiling to identify men in the general population (PDF Format)Barriers to prescribing targeted therapies for NSCLC patients with highly actionable gene variants in the VA (Video MP4 Format)Basal subtype and clinical estrogen receptor status of genomically basal breast tumors in (Video MP4 Format)Baseline circulating tumor cell (CTC) count as a prognostic marker of PSA response and progression in metastatic castrate (Video MP4 Format)Baseline circulating tumor cell (CTC) count as a prognostic marker of PSA response and progression in metastatic castrate (PDF Format)Battle of the Clones Establishing the Leukemia Roadmap (Video MP4 Format)Benefits of an early mobility program for hospitalized cancer patients A pilot study (Video MP4 Format)Benefits of an early mobility program for hospitalized cancer patients A pilot study (PDF Format)BET inhibitor molibresib for the treatment of advanced solid tumors Final results from an open-label phase I II study (Video MP4 Format)Better and Safer Surgery for Gastroesophageal Cancer (Video MP4 Format)Beyond PACIFIC Balancing Benefit and Risk (Video MP4 Format)Beyond Sedlis A novel, histology-based nomogram for predicting recurrence risk and need for adjuvant radiation (Video MP4 Format)Big Changes in the Care of Metastatic Disease (Video MP4 Format)Big Changes in the Care of Metastatic Disease (PDF Format)Biomarker analyses from the phase III CheckMate 214 trial of nivolumab plus ipilimumab (N+I) or sunitinib (S) (Video MP4 Format)Biomarker analyses from the phase III CheckMate 214 trial of nivolumab plus ipilimumab (N+I) or sunitinib (S) (PDF Format)Biomarker analysis from a phase I study using gedatolisib+palbociclib+hormone therapy in ER+ HER2- metastatic (Video MP4 Format)Biomarker analysis from the KEYNOTE-199 trial of pembrolizumab in patients (pts) with docetaxel-refractory metastatic (Video MP4 Format)Biomarker data from KATHERINE A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) (Video MP4 Format)Biomarker data from KATHERINE A phase III study of adjuvant trastuzumab emtansine (T-DM1) versus trastuzumab (H) (PDF Format)Biomarkers of Single Agent Versus Combination Checkpoint Inhibitors in Advanced Renal Cell Carcinoma (Video MP4 Format)Biomarkers of Single Agent Versus Combination Checkpoint Inhibitors in Advanced Renal Cell Carcinoma (PDF Format)Bispecifics A ‘Two for One’ Strategy (Video MP4 Format)Bispecifics A ‘Two for One’ Strategy (PDF Format)Bortezomib induction prior to autologous hematopoietic cell transplantation (AHCT) for newly diagnosed light (Video MP4 Format)Bosutinib (BOS) for chronic phase (CP) chronic myeloid leukemia (CML) after imatinib (IMA) failure (Video MP4 Format)Bosutinib (BOS) for chronic phase (CP) chronic myeloid leukemia (CML) after imatinib (IMA) failure (PDF Format)Bosutinib in patients with chronic phase chronic myeloid leukemia intolerant to prior tyrosine kinase inhibitors (Video MP4 Format)Brain Tumor Microenvironment Exploring New Territory (Video MP4 Format)BRCA testing concordance with national guidelines for patients with breast cancer in community cancer programs (Video MP4 Format)Breaking Bad Evaluating Efficacy of Old and New Drugs on Symptom Management (Video MP4 Format)Breaking Bad Evaluating Efficacy of Old and New Drugs on Symptom Management (PDF Format)Breast Cancer – Local Regional Adjuvant (Video MP4 Format)Breast Cancer – Local Regional Adjuvant (PDF Format)Breast Cancer – Metastatic (Video MP4 Format)Breast Cancer – Metastatic (PDF Format)Breast cancer events in women with atypical ductal hyperplasia who do not undergo surgical excision (Video MP4 Format)Breast cancer grade and clinical benefit in patients with advanced breast cancer treated with an engineered (Video MP4 Format)Breast Cancer Index (BCI) predicts benefit of two-and-a-half versus five years of extended endocrine therapy (Video MP4 Format)Brentuximab vedotin in combination with nivolumab, doxorubicin, and dacarbazine in newly diagnosed patients (Video MP4 Format)BT5528-100 phase I II study of the safety, pharmacokinetics, and preliminary clinical activity of BT5528 in patients (Video MP4 Format)B-TREUH A single-arm phase II pilot study of euthyroid hypothyroxinemia in metastatic breast carcinoma (Video MP4 Format)Building a New Model Innovations in Educating the Trainee and Community (Video MP4 Format)Burnout among oncology physician assistants (PAs) from 2015 to 2019 (Video MP4 Format)Burnout Is Universal It’s Not Just a Problem for American Physicians (Video MP4 Format)CA209-9JC A phase II study of first-line nivolumab (NIVO) in patients (pts) with locally advanced or metastatic (Video MP4 Format)Cabozantinib (cabo) combined with durvalumab (durva) in gastroesophageal (GE) cancer and other gastrointestinal (GI) (Video MP4 Format)Cabozantinib in combination with atezolizumab in non-small cell lung cancer (NSCLC) patients previously treated (Video MP4 Format)Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer (Video MP4 Format)Cabozantinib in combination with atezolizumab in urothelial carcinoma previously treated with platinum-containing chemotherapy (Video MP4 Format)Can Antibody-Based Therapy Replace Chemotherapy in Hodgkin Lymphoma (Video MP4 Format)Can FIT rule out colorectal cancer in symptomatic patients Diagnostic test accuracy results from 9,822 patients (Video MP4 Format)Can sentinel node biopsy after neoadjuvant systemic chemotherapy (NAC) be safely omitted in selected patient (Video MP4 Format)Cancer of Unknown Primary How Did We Get Here (Video MP4 Format)Cancer of Unknown Primary How Did We Get Here (PDF Format)Cancer Prevention, Risk Reduction, and Genetics (Video MP4 Format)Cancer Prevention, Risk Reduction, and Genetics (PDF Format)CANOPY-A A phase III, multicenter, randomized, double-blind, placebo-controlled trial evaluating canakinumab (Video MP4 Format)Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC) (Video MP4 Format)Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC) (PDF Format)Capmatinib in patients with METex14-mutated or high-level MET-amplified advanced non-small-cell lung cancer (NSCLC) (Video MP4 Format)Carboplatin versus cisplatin for the treatment of extensive-stage small cell lung cancer (SCLC) A National VA Database analysis (Video MP4 Format)CARD Overall survival (OS) analysis of patients with metastatic castration-resistant prostate cancer (mCRPC) (Video MP4 Format)Cardiomyopathy risk among childhood cancer survivors of African ancestry and its molecular mechanisms (Video MP4 Format)Cardiomyopathy risk among childhood cancer survivors of African ancestry and its molecular mechanisms (PDF Format)Care Delivery and Regulatory Policy (Video MP4 Format)Care Delivery and Regulatory Policy (PDF Format)Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) (Video MP4 Format)Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) (PDF Format)Caring for transgender cancer patients Shortcomings of medical education (Video MP4 Format)CARS and BITES in the Fight (Video MP4 Format)Castleman disease spectrum (Video MP4 Format)CC-486 is safe and well-tolerated as maintenance therapy in elderly patients (75 years) with acute myeloid leukemia (AML) (Video MP4 Format)CCTG BR.34 A randomized trial of durvalumab and tremelimumab + – platinum-based chemotherapy in patients (Video MP4 Format)CCTG BR.34 A randomized trial of durvalumab and tremelimumab + – platinum-based chemotherapy in patients (PDF Format)CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL) (Video MP4 Format)CD19-targeted chimeric antigen receptor (CAR) T cells in CNS relapsed acute lymphoblastic leukemia (ALL) (PDF Format)CD3 and CD20 immune cell densities in primary tumors, lymph node metastasis, and recurrent disease (Video MP4 Format)Cediranib in combination with olaparib in patients without a germline BRCA1 2 mutation with recurrent (Video MP4 Format)Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer (Video MP4 Format)Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer (PDF Format)Cell-free DNA comparative analysis of hormone receptor-positive, first-line metastatic breast cancer genomic landscape (Video MP4 Format)Cell-Free DNA in the Management of Glioma CSF Versus Blood (Video MP4 Format)Cell-Free DNA in the Management of Glioma CSF Versus Blood (PDF Format)Central Nervous System Tumors (Video MP4 Format)Central Nervous System Tumors (PDF Format)Cetuximab irinotecan 5-FU + -oxaliplatin or FOLFOXIRI + – bevacizumab in patients with colorectal cancer (Video MP4 Format)CIFeR A novel Clinician-lead Intervention to address Fear of cancer Recurrence (FCR) in breast cancer survivors (Video MP4 Format)Circulating tumor cells (CTCs) with small-cell like pathology are prevalent in metastatic castration (Video MP4 Format)Circulating tumor DNA (ctDNA) dynamics associate with treatment response and radiological progression-free survival (rPFS) (Video MP4 Format)Circulating tumor DNA (ctDNA) dynamics associate with treatment response and radiological progression-free survival (rPFS) (PDF Format)Circulating tumor DNA dynamics to predict cancer recurrence metastasis in Chinese pathologic stage I lung adenocarcinoma (Video MP4 Format)Circulating tumor DNA to detect minimal residual disease, response to adjuvant therapy, and identify patients (Video MP4 Format)Cisplatin every three weeks versus weekly cisplatin or carboplatin with definitive radiotherapy for squamous cell (Video MP4 Format)Clarifying the Role of IMID Combinations in Peripheral T-cell Lymphoma and Diffuse Large B-cell Lymphoma (Video MP4 Format)Clinical activity of cirmtuzumab, an anti-ROR1 antibody, in combination with ibrutinib (Video MP4 Format)Clinical activity of MCLA-128 (zenocutuzumab) in combination with endocrine therapy (ET) in ER+ HER2-low (Video MP4 Format)Clinical activity of the RET inhibitor pralsetinib (BLU-667) in patients with RET fusion+ solid tumors (Video MP4 Format)Clinical activity of the RET inhibitor pralsetinib (BLU-667) in patients with RET fusion+ solid tumors (PDF Format)Clinical and genetic risk factors for radiation-associated ototoxicity A report from the childhood cancer survivor (Video MP4 Format)Clinical and pathologic factors associated with survival in BRAFV600E colorectal cancers (Video MP4 Format)Clinical characteristics and anti-PD-(L)1 treatment outcomes of KRAS-G12C mutant lung cancer compared (Video MP4 Format)Clinical characteristics, genomic features, and recurrence risk of early-stage MET exon 14 mutant non-small cell lung cancer (NSCLC) (Video MP4 Format)Clinical impact of COVID-19 on patients with cancer Data from the COVID-19 and Cancer Consortium (CCC19) (Video MP4 Format)Clinical impact of COVID-19 on patients with cancer Data from the COVID-19 and Cancer Consortium (CCC19) (PDF Format)Clinical impact of targetable gene alterations on therapeutic outcomes in stage II III locally advanced non-small cell lung cancer patients (Video MP4 Format)Clinical outcome of patients experiencing central nervous system progression on first-line pertuzumab (Video MP4 Format)Clinical outcomes with early-elective discontinuation of PD-1 inhibitors (PDi) at one year in patients (pts) with metastatic melanoma (MM) (Video MP4 Format)Clinical performance of a comprehensive novel liquid biopsy test for identifying non-small cell lung cancer (NSCLC) patients (Video MP4 Format)Clinical significance of CTC enumeration on the Epic Sciences platform in metastatic castration-resistant (Video MP4 Format)Clinical value of atezolizumab + bevacizumab for first-line unresectable hepatocellular carcinoma (HCC) (Video MP4 Format)Clinicopathologic and molecular profile of Philadelphia like ALL in Hispanic population of Central Valley California (Video MP4 Format)Clinicopathologic characteristics and immunotherapy outcomes in SMARCA4-mutant (mut) non-small cell lung cancer (NSCLC) (Video MP4 Format)Cobimetinib plus gemcitabine is an active combination in KRAS G12R-mutated in previously chemotherapy-treated (Video MP4 Format)CodeBreak 100 Activity of AMG 510, a novel small molecule inhibitor of KRASG12C, in patients with advanced colorectal cancer (Video MP4 Format)CodeBreak 100 Phase I study of AMG 510, a novel KRASG12C inhibitor, in patients (pts) with advanced solid tumors (Video MP4 Format)Colorectal cancer under the age of 50 years in U.S. Department of Veterans Affairs Is there a role of early screening (Video MP4 Format)Combination anti-PD-1 and ipilimumab (ipi) therapy in patients with advanced melanoma and pre-existing autoimmune disorders (AD) (Video MP4 Format)Coming to a Microenvironment Near You (Video MP4 Format)Coming to a Microenvironment Near You (PDF Format)Common Problems and Rare Breakthroughs (Video MP4 Format)Common Problems and Rare Breakthroughs (PDF Format)Comparative analysis of characteristics, survival trends, and associated malignancies of B-cell and T-cell prolymphocytic leukemia (Video MP4 Format)Comparative effectiveness of second-line (2L) single-agent atezolizumab (A), nivolumab (N), and pembrolizumab (P) (Video MP4 Format)Comparative study of therapy-related (tALL) and de novo adult acute lymphoblastic leukemia (dnALL) (Video MP4 Format)Comparing and assessing the reported penetrance of cancer susceptibility genes for breast cancer (Video MP4 Format)Comparison of chemotherapy dose intensity for AYAs on COG AALL1131 versus CALGB 10403 (Video MP4 Format)Comparison of different systemic therapeutic regimes in resectable high-risk soft tissue sarcoma (Video MP4 Format)Comparison of efficacy and safety with obinutuzumab plus chemotherapy versus rituximab plus chemotherapy in patients (Video MP4 Format)Comparison of recurrence patterns after surgery and radiation therapy with 68Ga-PSMA-11 PET CT in nonmetastatic (Video MP4 Format)Comparison of two chemotherapy regimens in Ewing sarcoma (ES) Overall and subgroup results of the Euro Ewing 2012 (PDF Format)Complete human papillomavirus vaccination coverage over a 13-year period in a large population of privately (Video MP4 Format)Complete responses (CR) in patients receiving atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in IMbrave150 (Video MP4 Format)Completing the Circle for EGFR-Directed Therapies (Video MP4 Format)Composite grading algorithm for National Cancer Institute’s PRO-CTCAE (Video MP4 Format)Comprehensive analysis of HER2 status through genomic, transcription, and translation among 5,305 patients (Video MP4 Format)Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC) (Video MP4 Format)Comprehensive breast cancer (BC) risk assessment for CHEK2 carriers incorporating a polygenic risk score (PRS) (Video MP4 Format)Comprehensive breast cancer (BC) risk assessment for CHEK2 carriers incorporating a polygenic risk score (PRS) (PDF Format)Comprehensive profiling of androgen receptor-positive (AR+) triple-negative breast cancer (TNBC) patients (pts) (Video MP4 Format)Computational discovery of non-mutational tumor-restricted antigens reveals evidence of immunoediting (Video MP4 Format)Concordance study of treatment guidance from an online patient assistance algorithm (OCPAP) and treatment (Video MP4 Format)Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated non-small cell lung cancer (NSCLC) (Video MP4 Format)Concurrent osimertinib plus gefitinib for first-line treatment of EGFR-mutated non-small cell lung cancer (NSCLC) (PDF Format)Consensus molecular subtype (CMS) as a novel integral biomarker in colorectal cancer (Video MP4 Format)Consensus molecular subtypes (CMS) as a marker for treatment and disease biology in metastatic colorectal cancer (CRC) (Video MP4 Format)Consensus molecular subtypes and CRCassigner classifications in metastatic colorectal cancer (mCRC) (Video MP4 Format)Continuing the PARP Journey (Video MP4 Format)Continuing the PARP Journey (PDF Format)Continuing treatment Is it worth it (Video MP4 Format)Continuing treatment Is it worth it (PDF Format)Controlled IL-12 in combination with a PD-1 inhibitor subjects with recurrent glioblastoma (Video MP4 Format)Correlation between overall response rate and progression-free survival overall survival in comparative trials (Video MP4 Format)Correlation of baseline molecular and clinical variables with ALK inhibitor efficacy in ALTA-1L (Video MP4 Format)Correlation of pathogenic POLE mutations with clinical benefit to immune checkpoint inhibitor therapy (Video MP4 Format)Correlation of pathogenic POLE mutations with clinical benefit to immune checkpoint inhibitor therapy (PDF Format)Corticosteriod tapering in patients (Pts) with relapsed or refractory multiple myeloma (RRMM) receiving (Video MP4 Format)CT-based radiomic classifier of primary renal tumors to distinguish between metastatic and non-metastatic disease (Video MP4 Format)CTEP 9557 A dose-escalation trial of combination dabrafenib, trametinib, and AT13387 in patients with BRAF (Video MP4 Format)CTONG1104 Adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation (Video MP4 Format)CTONG1104 Adjuvant gefitinib versus chemotherapy for resected N1-N2 NSCLC with EGFR mutation (PDF Format)CULMINATE A phase II study of cusatuzumab + azacitidine in patients with newly diagnosed AML, ineligible for intensive chemotherapy (Video MP4 Format)CX-2009, a CD166-directed probody drug conjugate (PDC) Results from the first-in-human study in patients (Pts) (Video MP4 Format)CX-2029, a PROBODY drug conjugate targeting CD71 (transferrin receptor) Results from a first-in-human study (Video MP4 Format)CX-2029, a PROBODY drug conjugate targeting CD71 (transferrin receptor) Results from a first-in-human study (PDF Format)CYAD-101 An innovative non-gene edited allogeneic CAR-T for solid tumor cancer therapy (Video MP4 Format)Change in cardiac function with CPX-351 in relapsed pediatric AML A Children’s Oncology Group (COG) report from AAML1421 (Video MP4 Format)Changes in cancer mortality rates after the adoption of the Affordable Care Act (Video MP4 Format)Changes in cancer mortality rates after the adoption of the Affordable Care Act (PDF Format)Characteristics and outcomes of real-world (RW) patients (pts) with microsatellite instability-high (MSI-H) solid tumors (Video MP4 Format)Characterization of 1,387 NSCLCs with MET exon 14 (METex14) skipping alterations (SA) and potential acquired resistance (AR) (Video MP4 Format)Characterization of 1,387 NSCLCs with MET exon 14 (METex14) skipping alterations (SA) and potential acquired resistance (AR) (PDF Format)Characterization of clonal hematopoiesis of indeterminate potential mutations from germline whole exome sequencing data (Video MP4 Format)Characterization of NRG1 gene fusion events in solid tumors (Video MP4 Format)Characterization of patients (pts) with long-term responses to rucaparib in recurrent ovarian cancer (OC) (Video MP4 Format)Characterization of patients with multiple primary tumors (Video MP4 Format)Characterization of patients with multiple primary tumors (PDF Format)Characterizing Long-Term Outcomes in Metastatic Melanoma in 2020 (Video MP4 Format)CheckMate 067 Long-term outcomes in patients with mucosal melanoma (Video MP4 Format)Checkmate 77T A phase III trial of neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed (Video MP4 Format)Checkpoint inhibitor treatment-related cutaneous adverse events in skin of color patients at Memorial Sloan Kettering Cancer Center (Video MP4 Format)Chemo-immunotherapy in Small Cell Lung Cancer Many Questions Remain (Video MP4 Format)Chemo-immunotherapy in Small Cell Lung Cancer Many Questions Remain (PDF Format)Chemotherapy (CT) de-escalation using an FDG-PET CT (F-PET) and pathological response-adapted strategy (Video MP4 Format)Chemotherapy (CT) de-escalation using an FDG-PET CT (F-PET) and pathological response-adapted strategy (PDF Format)Chemotherapy remote care monitoring program (CRCMP) Integration of an SMS text patient-reported outcome (PRO) (Video MP4 Format)Chemotherapy remote care monitoring program (CRCMP) Integration of an SMS text patient-reported outcome (PRO) (PDF Format)Chew on This Reintroduction of Induction, in Oral Cavity, No Less (Video MP4 Format)Dabrafenib + trametinib combination therapy in pediatric patients with BRAF V600-mutant low-grade glioma (Video MP4 Format)Dabrafenib + trametinib combination therapy in pediatric patients with BRAF V600-mutant low-grade glioma (PDF Format)DaroACT Darolutamide and enzalutamide effects on physical and neurocognitive function and daily activity in patients (Video MP4 Format)Deciphering Clonal Hematopoiesis Not a CHIP Shot (Video MP4 Format)Deep learning for improved prediction of late-onset cardiomyopathy among childhood cancer survivors (Video MP4 Format)Deep learning to identify high-risk smokers for lung cancer screening from chest radiographs (Video MP4 Format)De-escalated chemotherapy versus endocrine therapy plus pertuzumab+ trastuzumab for HR+ HER2+ (Video MP4 Format)Defining patient-elicited concepts unique to adolescents and young adults with cancer (Video MP4 Format)Defining the mutational landscape of 3,217 primary breast cancer transcriptomes through large-scale RNA-seq (Video MP4 Format)Delivery of cancer survivorship education to community health care professionals (Video MP4 Format)Depression, anxiety, and patterns of mental health care among men with prostate cancer on androgen deprivation therapy (ADT) (Video MP4 Format)Depth of response to isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma (Video MP4 Format)Depth of response to isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma (PDF Format)Design and rationale of MASTERKEY-115 phase II trial of talimogene laherparepvec (T-VEC) with pembrolizumab (pembro) in patients (Video MP4 Format)Detection of actionable gene mutations in breast cancer by amplicon-based next-generation sequencing liquid (Video MP4 Format)Developing South Asia’s first structured head and neck surgery multicenter fellowship initiative (Video MP4 Format)Development and validation of a pediatric disease risk index for allogeneic hematopoietic cell transplantation (Video MP4 Format)Development and validation of a pediatric disease risk index for allogeneic hematopoietic cell transplantation (PDF Format)Development and validation of an early death risk score for older patients treated with chemotherapy for cancer (Video MP4 Format)Development and validation of natural language processing (NLP) algorithm for detection of distant versus local (Video MP4 Format)Development of drug resistance in colon cancer patients following chemotherapy, a contributing factor in the failure (Video MP4 Format)Developmental Therapeutics-Immunotherapy (Video MP4 Format)Developmental Therapeutics-Immunotherapy (PDF Format)Developmental Therapeutics-Molecularly Targeted Agents and Tumor Biology (Video MP4 Format)Developmental Therapeutics-Molecularly Targeted Agents and Tumor Biology (PDF Format)Dexrazoxane and heart function among long-term childhood cancer survivors A Children’s Oncology Group study (Video MP4 Format)Dexrazoxane and heart function among long-term childhood cancer survivors A Children’s Oncology Group study (PDF Format)Diagnosis of leptomeningeal metastasis (LM) through identification of circulating tumor cells (CTCs) in cerebrospinal fluid (CSF) (Video MP4 Format)Dietary advanced glycation end products (AGEs) and breast cancer mortality in the women’s health initiative (WHI) (Video MP4 Format)Different response to ALK inhibitors in EML4-ALK positive mediastinal cancer of unknown primary (Video MP4 Format)Different response to ALK inhibitors in EML4-ALK positive mediastinal cancer of unknown primary (PDF Format)Discovery of a novel shared tumor antigen in human lung cancer (Video MP4 Format)Discussion – Redefining Cancer of Unknown Primary Is Genomics the Answer (Video MP4 Format)Discussion of LBA1 (Video MP4 Format)Discussion of LBA1 (PDF Format)Discussion of LBA2 (Video MP4 Format)Discussion of LBA2 (PDF Format)Discussion of LBA3 (Video MP4 Format)Discussion of LBA3 (PDF Format)Discussion of LBA4 (Video MP4 Format)Discussion of LBA4 (PDF Format)Discussion of LBA5 (Video MP4 Format)Discussion of LBA5 (PDF Format)Dissecting Out Improved Outcomes (Video MP4 Format)Dissecting Out Improved Outcomes (PDF Format)Dissecting outcomes of patients (pts) with ypT2N0 disease after neoadjuvant chemotherapy (NAC) for muscle invasive (Video MP4 Format)Diversity in Oncology Towards Evidence-Based Transformation (Video MP4 Format)Does sinonasal cancer survival differ based on human papillomavirus status (Video MP4 Format)Does the Patient Know Best (Video MP4 Format)Does the Patient Know Best (PDF Format)Dollars and Sense Reducing Physical and Financial Toxicity (Video MP4 Format)Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma An open-label, randomized (Video MP4 Format)Donafenib versus sorafenib as first-line therapy in advanced hepatocellular carcinoma An open-label, randomized (PDF Format)Dose and volume de-escalation for HPV-associated oropharyngeal cancer Long-term follow-up of the OPTIMA trial (Video MP4 Format)DREAMM-2 Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed refractory multiple myeloma (RRMM) and high-risk (HR) cytogenetics (Video MP4 Format)DREAMM-2 Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed refractory multiple myeloma (RRMM) and renal impairment (Video MP4 Format)DREAMM-5 platform trial Belantamab mafodotin in combination with novel agents in patients with relapsed (Video MP4 Format)DREAMM-6 Safety and tolerability of belantamab mafodotin in combination with bortezomib (Video MP4 Format)DREAMM-6 Safety and tolerability of belantamab mafodotin in combination with bortezomib (PDF Format)DREAMM-9 Phase III study of belantamab mafodotin plus VRd versus VRd alone in transplant-ineligible newly (Video MP4 Format)Driving quality improvement How clinical decision support can facilitate compliance with evidence-based pathways (Video MP4 Format)Drugs Old and New for Metastatic Breast Cancer (PDF Format)DUO-E GOG-3041 ENGOT-EN10 a randomized phase III trial of first-line carboplatin (carb) and paclitaxel (pac) (Video MP4 Format)Durvalumab ñ tremelimumab + platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC) (Video MP4 Format)Durvalumab ñ tremelimumab + platinum-etoposide in first-line extensive-stage SCLC (ES-SCLC) (PDF Format)Durvalumab and tremelimumab in combination with FOLFOX in patients with RAS-mutated, microsatellite-stable (Video MP4 Format)Durvalumab and tremelimumab in combination with FOLFOX in patients with RAS-mutated, microsatellite-stable (PDF Format)DUTRENEO Trial A randomized phase II trial of DUrvalumab and TREmelimumab versus chemotherapy (Video MP4 Format)DUTRENEO Trial A randomized phase II trial of DUrvalumab and TREmelimumab versus chemotherapy (PDF Format)Early ctDNA response assessment for prediction of platinum sensitivity in small cell lung cancer (Video MP4 Format)Early discontinuation to adjuvant endocrine therapy in the ECOG-ACRIN TAILORx Trial (Video MP4 Format)Early discontinuation to adjuvant endocrine therapy in the ECOG-ACRIN TAILORx Trial (PDF Format)Early pulmonary function changes associated with brigatinib initiation (Video MP4 Format)Early results of TROPHY-U-01 Cohort 2 Sacituzumab govitecan (SG) in platinum-ineligible patients (pts) (Video MP4 Format)Early safety from a phase I, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) (Video MP4 Format)Early-stage breast cancer (BC) patients Factors associated with aromatase inhibitor-induced musculoskeletal (Video MP4 Format)ECOG-ACRIN tomosynthesis mammographic imaging screening trial (EA1151) (Video MP4 Format)Effect of a supportive medicine program for cancer patients on patient connectivity to care and health care utilization (Video MP4 Format)Effect of anlotinib in advanced small cell lung cancer (SCLC) patients relapsed within three months after second-line treatment (Video MP4 Format)Effect of early blood counts on overall survival (OS) following glasdegib + LDAC in newly diagnosed AML (Video MP4 Format)Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy (Video MP4 Format)Effect of enasidenib (ENA) plus azacitidine (AZA) on complete remission and overall response versus AZA monotherapy (PDF Format)Effect of first-line spartalizumab + dabrafenib + trametinib on immunosuppressive features detected in peripheral blood (Video MP4 Format)Effect of integrating machine learning mortality estimates with behavioral nudges to increase serious illness conversions (Video MP4 Format)Effect of integrating machine learning mortality estimates with behavioral nudges to increase serious illness conversions (PDF Format)Effect of linguistic acculturation on self-efficacy and anxiety in caregivers of Latina breast cancer survivors (Video MP4 Format)Effect of live education targeted to genetic counselors on knowledge and competence (Video MP4 Format)Effect of participation in the annual Immuno-oncology Young Investigators’ Forum (IOYIF) on the competency (Video MP4 Format)Effect of pembrolizumab (pembro) on hepatitis B viral (HBV) load and aminotransferase (ALT) levels in patients (pts) (Video MP4 Format)Effect of performance status on survival with pembrolizumab monotherapy in advanced non-small cell lung cancer (NSCLC) (Video MP4 Format)Effect of shorter time to treatment on survival in rural patients with breast cancer (Video MP4 Format)Effect of video-based patient education on pancreatic cancer knowledge and behavior (Video MP4 Format)Effect on response to neoadjuvant chemotherapy in high-grade serous ovarian cancer by inhibiting the GAS6 AXL pathway (Video MP4 Format)Effectiveness of adjuvant FOLFOX versus 5FU for colon cancer treatment in community oncology practice (Video MP4 Format)Effects of electroacupuncture and auricular acupuncture for chronic pain in cancer survivors (Video MP4 Format)Effects of electroacupuncture and auricular acupuncture for chronic pain in cancer survivors (PDF Format)Effects of GC4419 (avasopasem manganese) on chronic kidney disease in head and neck cancer patients (Video MP4 Format)Effects of YOCAS yoga, cognitive behavioral therapy, and survivorship health education on insomnia (Video MP4 Format)Effects of YOCAS yoga, cognitive behavioral therapy, and survivorship health education on insomnia (PDF Format)Efficacy and safety in older patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel (CBZ) (Video MP4 Format)Efficacy and safety of ABP 798 compared with rituximab Results from the comparative clinical study in patients with non-Hodgkin’s (Video MP4 Format)Efficacy and safety of carfilzomib, dexamethasone, daratumumab (KdD) twice-weekly at 56 mg m2 and once-weekly at 70 mg m2 (Video MP4 Format)Efficacy and safety of entrectinib in patients (pts) with NTRK-fusion positive (NTRK-fp) solid tumors An updated integrated analysis (Video MP4 Format)Efficacy and safety of olaparib according to age in BRCA-1 2 mutated patients with recurrent platinum-sensitive ovarian cancer (Video MP4 Format)Efficacy and safety of surufatinib in United States (US) patients (pts) with neuroendocrine tumors (NETs) (Video MP4 Format)Efficacy and safety of the antibody-drug conjugate (ADC) SAR408701 in patients (pts) with non-squamous (Video MP4 Format)Efficacy and safety of the antibody-drug conjugate (ADC) SAR408701 in patients (pts) with non-squamous (PDF Format)Efficacy of add-on treosulfan and melphalan high-dose therapy in patients with high-risk metastatic Ewing sarcoma (PDF Format)Efficacy of ear acupuncture on sleep quality in breast cancer survivors A randomized controlled trial (Video MP4 Format)Efficacy of enzalutamide (ENZA) + androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer (mHSPC) (Video MP4 Format)Efficacy of neoadjuvant chemotherapy (NAC) in male breast cancer (MaBC) compared with female breast cancer (FBC) (Video MP4 Format)Efficacy of SCRI-CAR19x22 T cell product in B-ALL and persistence of anti-CD22 activity (Video MP4 Format)Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) (Video MP4 Format)Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) (PDF Format)Emerging Biomarkers of Checkpoint Inhibitors-Based Combinations in Urothelial Cancer (Video MP4 Format)Emerging Biomarkers of Checkpoint Inhibitors-Based Combinations in Urothelial Cancer (PDF Format)Emerging Immunotherapy for Glioma What Justifies Phase III Testing (Video MP4 Format)Emerging Immunotherapy for Glioma What Justifies Phase III Testing (PDF Format)Emerging Unmet Needs in RCC An Ideal Sequential Strategy and the Post-immunotherapy Space (Video MP4 Format)Emerging Unmet Needs in RCC An Ideal Sequential Strategy and the Post-immunotherapy Space (PDF Format)Emotional distress, stress, and cardiovascular health in adult survivors of childhood cancer (Video MP4 Format)Encorafenib plus cetuximab with or without binimetinib for BRAF V600E metastatic colorectal cancer (Video MP4 Format)Encorafenib plus cetuximab with or without binimetinib for BRAF V600E metastatic colorectal cancer (PDF Format)Encorafenib plus cetuximab with or without binimetinib for BRAF V600E-mutant metastatic colorectal cancer (Video MP4 Format)Endometrial Cancer and SCCOHT Small Studies, Big Impact (Video MP4 Format)Endometrial Cancer and SCCOHT Small Studies, Big Impact (PDF Format)Ensuring Cancer Research Progress During a Global Pandemic (Video MP4 Format)Ensuring Cancer Research Progress During a Global Pandemic (PDF Format)ENGOT-EN6 NSGO-RUBY A phase III, randomized, double-blind, multicenter study of dostarlimab + carboplatin-paclitaxel (Video MP4 Format)ENGOT-OV44 FIRST study a randomized, double-blind, adaptive, phase III study of standard of care (SOC) platinum-based (Video MP4 Format)Enhanced coping and self-efficacy in caregivers of hematopoietic stem cell transplant (HCT) recipients (Video MP4 Format)Enhanced efficacy of anti-VEGFR2 taxane therapy after progression on immune checkpoint inhibition (ICI) in patients (pts) (Video MP4 Format)Enhancing cancer literacy among Appalachian Kentucky middle and high school students (Video MP4 Format)Enhancing Decision-Making in Advanced Breast Cancer (Video MP4 Format)Epcoritamab (GEN3013; DuoBody-CD3xCD20) to induce complete response in patients with relapsed (Video MP4 Format)Epigenetic control of breast cancer susceptibility (Video MP4 Format)Equivalence randomized trial comparing treatment based on sentinel node biopsy versus neck dissection (Video MP4 Format)Equivalence randomized trial comparing treatment based on sentinel node biopsy versus neck dissection (PDF Format)ERBB2 amplifications and mutations in 109 advanced breast cancer patients by next-generation sequencing (Video MP4 Format)ERDAFITINIB in locally advanced or metastatic urothelial carcinoma (mUC) Long-term outcomes in BLC2001 (Video MP4 Format)Escalated dosing schedules of CC-486 for patients experiencing first acute myeloid leukemia (AML) relapse (Video MP4 Format)ESPAC-4 A multicenter, international, open-label randomized controlled phase III trial of adjuvant combination (Video MP4 Format)ESPAC-5F Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared (Video MP4 Format)ESPAC-5F Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared (PDF Format)Establishing analytical and clinical similarity between HD201 and herceptin (Video MP4 Format)Establishment of the first international large-scale, genomic screening platform to identify patients with rare oncogene (Video MP4 Format)Estimating treatment-free survival (TFS) over extended follow-up in patients (pts) with advanced melanoma (MEL) (Video MP4 Format)Etanercept with extracorporeal photopheresis (ECP) for steroid-refractory acute graft versus host disease following (Video MP4 Format)EV-202 A phase II study of enfortumab vedotin in patients with select previously treated locally advanced (Video MP4 Format)Evaluating barriers to uptake of comprehensive genomic profiling (CGP) in advanced cancer patients (pts) (Video MP4 Format)Evaluation of a computational decision support system for molecularly targeted treatment planning by the clinical (Video MP4 Format)Evaluation of an individualized starting-dose of niraparib in the PRIMA ENGOT-OV26 GOG-3012 study (Video MP4 Format)Evaluation of blood TMB (bTMB) in KEYNOTE-189 Pembrolizumab (pembro) plus chemotherapy (chemo) (Video MP4 Format)Evaluation of blood TMB (bTMB) in KEYNOTE-189 Pembrolizumab (pembro) plus chemotherapy (chemo) (PDF Format)Evaluation of CD22 modulation as a mechanism of resistance to inotuzumab ozogamicin (InO) (Video MP4 Format)Evaluation of DNA repair biology signatures to predict specific carboplatin (C) versus docetaxel (D) benefit (Video MP4 Format)Evaluation of predictive biomarkers for nivolumab in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) (Video MP4 Format)Evaluation of safety, immunogenicity, and preliminary efficacy of PolyPEPI1018 off-the-shelf vaccine with fluoropyrimidine (Video MP4 Format)Evaluation of spatiotemporal heterogeneity of PDL1 expression in gastroesophageal adenocarcinoma (GEA) at baseline (Video MP4 Format)Evaluation of spatiotemporal heterogeneity of tumor mutational burden (TMB) in gastroesophageal adenocarcinoma (GEA) (Video MP4 Format)Evaluation of the correlation between antibiotic use and survival in patients with recurrent or metastatic head (Video MP4 Format)Evaluation of the correlation between antibiotic use and survival in patients with recurrent or metastatic head (PDF Format)Evaluation of the incidence of pneumonitis in United States veterans with non-small cell lung cancer receiving (Video MP4 Format)Even the Gold Standard Can be Refined The Strength and Limitations of Randomized Clinical Trials (Video MP4 Format)Even the Gold Standard Can be Refined The Strength and Limitations of Randomized Clinical Trials (PDF Format)Everything old is new again Modulation and delivery of topoisomerase I mediated DNA damage (Video MP4 Format)Evidence of intratumoral localization, activation, and immunomodulatory effect of CX-072, a probody therapeutic (Video MP4 Format)Evolving development of PD-1 therapy Cetrelimab (JNJ-63723283) from monotherapy to combination with erdafitinib (Video MP4 Format)Evolving risk of therapy-related myelodysplastic syndromes and acute myeloid leukemia (tMDS AML) following modern cancer therapies (Video MP4 Format)Exome scale liquid biopsy characterization of putative neoantigens and genomic biomarkers pre- and post anti-PD-1 (Video MP4 Format)Exomes and transcriptomes to reveal actionable findings in patients with negative-targeted panel sequencing (Video MP4 Format)Exosomal circular RNAs derived from serum Promising biomarkers for therapeutic targets and prognosis of (Video MP4 Format)Expanding criteria for prognostic stage IA disease in HR+ breast cancer (Video MP4 Format)Expanding Immunotherapy and Molecular Subtyping Into New Settings (Video MP4 Format)Expanding Immunotherapy and Molecular Subtyping Into New Settings (PDF Format)Expanding the Reach of MET-Directed Therapy (Video MP4 Format)Expanding the Reach of MET-Directed Therapy (PDF Format)Exploring impact of mutations in non-BRCA DNA damage response (DDR) and non-DDR genes on efficacy (Video MP4 Format)Expression of the senescence biomarker p16INK4a among childhood, adolescent, and young adult cancer survivors (Video MP4 Format)External validation of two predictive scores of chemotherapy toxicities among older patients with solid cancer (Video MP4 Format)Extrachromosomal DNA (ecDNA) carrying amplified oncogenes as a biomarker for insensitivity to checkpoint (Video MP4 Format)Factors associated with axillary conversion after neoadjuvant chemotherapy in initially node positive breast cancer (Video MP4 Format)Fatigue in long-term survivors with ovarian cancer Results of Expression VI – Carolin meets HANNA (Video MP4 Format)FDA analysis Impact of BMI on efficacy outcomes in multiple myeloma trials (Video MP4 Format)Feasibility and preliminary safety and efficacy of first-in-human intraperitoneal delivery of MCY-M11, anti-human-mesothelin (Video MP4 Format)Feasibility of olanzapine at reduced dose in highly emetogenic chemotherapy (Video MP4 Format)Feasibility of switching to S-1 after other fluoropyrimidine-related cardiotoxicity during chemotherapy for solid tumors (Video MP4 Format)Feeling the Burn Exposing Disparities in Radiation Oncology as a Benchmark for Change (Video MP4 Format)Final analysis of KEYNOTE-189 Pemetrexed-platinum chemotherapy (chemo) with or without pembrolizumab (pembro) (Video MP4 Format)Final analysis of phase I study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK) (Video MP4 Format)Final analysis of phase I study of ceritinib in pediatric patients with malignancies harboring activated anaplastic lymphoma kinase (ALK) (PDF Format)Final overall survival (OS) from PROSPER A phase III, randomized, double-blind, placebo (PBO) (Video MP4 Format)Final overall survival (OS) from PROSPER A phase III, randomized, double-blind, placebo (PBO) (PDF Format)Final overall survival (OS) results from SOLO2 ENGOT-ov21 A phase III trial assessing maintenance olaparib in patients (pts) (Video MP4 Format)Final overall survival (OS) results from SOLO2 ENGOT-ov21 A phase III trial assessing maintenance olaparib in patients (pts) (PDF Format)Final results from the KEYNOTE-100 trial of pembrolizumab in patients with advanced recurrent ovarian cancer (Video MP4 Format)Final results from the KEYNOTE-100 trial of pembrolizumab in patients with advanced recurrent ovarian cancer (PDF Format)Final results of a phase II trial of first-line FOLFIRINOX for advanced gastroesophageal cancers (Video MP4 Format)Final survival results from SPARTAN, a phase III study of apalutamide (APA) versus placebo (PBO) in patients (pts) (Video MP4 Format)Financial toxicity and patient-reported outcomes over time A longitudinal study of women with recurrent ovarian cancer (Video MP4 Format)Finding Our Blind Spot Innovation in LGBTQ+ Medical Education (Video MP4 Format)Finding Our Blind Spot Innovation in LGBTQ+ Medical Education (PDF Format)First safety and efficacy results of PRADO A phase II study of personalized response-driven surgery and adjuvant (Video MP4 Format)First safety and efficacy results of PRADO A phase II study of personalized response-driven surgery and adjuvant (PDF Format)First-in-human data of ALLO-501 and ALLO-647 in relapsed refractory large B-cell or follicular lymphoma (Video MP4 Format)First-in-human data of ALLO-501 and ALLO-647 in relapsed refractory large B-cell or follicular lymphoma (PDF Format)First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in patients (pts) (Video MP4 Format)First-in-human phase I study of HPN424, a tri-specific half-life extended PSMA-targeting T-cell engager in patients (Video MP4 Format)First-in-human phase I study of the novel CELMoD agent CC-92480 combined with dexamethasone (DEX) in patients (pts) (Video MP4 Format)First-in-human phase I study of the novel CELMoD agent CC-92480 combined with dexamethasone (DEX) in patients (pts) (PDF Format)First-in-human study of palcitoclax (APG-1252), a novel dual Bcl-2 Bcl-xL inhibitor, demonstrated advantages (Video MP4 Format)First-line biological agents plus chemotherapy in elderly patients with metastatic colorectal cancer A retrospective pooled analysis (Video MP4 Format)First-line durvalumab plus platinum-etoposide in extensive-stage (ES)-SCLC (CASPIAN) Impact of brain metastases (Video MP4 Format)First-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS-BRAF wild-type metastatic colorectal cancer elderly patients (Video MP4 Format)First-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS-BRAF wild-type metastatic colorectal cancer elderly patients (PDF Format)First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC) (Video MP4 Format)First-line tyrosine kinase inhibitor with or without aggressive upfront local radiation therapy in patients with EGFRm (Video MP4 Format)First-line tyrosine kinase inhibitor with or without aggressive upfront local radiation therapy in patients with EGFRm (PDF Format)Fishing for Complements Improving Symptoms Through Integrative Oncology (Video MP4 Format)Fishing for Complements Improving Symptoms Through Integrative Oncology (PDF Format)Five-year final results of a phase III study of CPX-351 versus 7+3 in older adults with newly diagnosed high-risk secondary AML (Video MP4 Format)Fixed-duration venetoclax-obinutuzumab for previously untreated patients with chronic lymphocytic leukemia (Video MP4 Format)FOENIX-CCA2 A phase II, open-label, multicenter study of futibatinib in patients (pts) with intrahepatic (Video MP4 Format)FOENIX-CCA2 A phase II, open-label, multicenter study of futibatinib in patients (pts) with intrahepatic (PDF Format)FOLFIRINOX de-escalation in advanced pancreatic cancer (aPC) A multicenter real-life study (Video MP4 Format)FOLFOXIRI bevacizumab (bev) versus doublets bev as initial therapy of unresectable metastatic colorectal cancer (mCRC) (Video MP4 Format)FOxTROT neoadjuvant FOLFOX chemotherapy with or without panitumumab (Pan) for patients (pts) with locally advanced (Video MP4 Format)FRACTION-RCC Innovative, high-throughput assessment of nivolumab + ipilimumab for treatment-refractory (Video MP4 Format)FRACTION-RCC Innovative, high-throughput assessment of nivolumab + ipilimumab for treatment-refractory (PDF Format)Frailty and neurocognitive decline in young adult survivors of childhood cancer A longitudinal analysis from the St. Jude lifetime cohort (Video MP4 Format)Frequency and prediction of non-medical opioid use behaviors (NMOU) among advanced cancer patients (Video MP4 Format)Frontline brentuximab vedotin as monotherapy or in combination for older Hodgkin lymphoma patients (Video MP4 Format)GAIN-2 Neo-adjuvant phase III trial to compare intense dose-dense chemotherapy (CT) to tailored dose-dense CT (Video MP4 Format)Gait speed and recommended treatment intensity among older adults with blood cancers (Video MP4 Format)Gastrointestinal Cancer-Colorectal and Anal (Video MP4 Format)Gastrointestinal Cancer-Colorectal and Anal (PDF Format)Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary (Video MP4 Format)Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary (PDF Format)GEN-009, a neoantigen vaccine containing ATLAS selected neoantigens, to generate broad sustained immunity against (Video MP4 Format)Gender differences in faculty rank and subspecialty choice in academic medical oncology (Video MP4 Format)Genetic profiling and the response to RET inhibitors in RET fusion positive non-small cell lung cancer (NSCLC) (Video MP4 Format)Genitourinary Cancer-Kidney and Bladder (Video MP4 Format)Genitourinary Cancer-Kidney and Bladder (PDF Format)Genitourinary Cancer-Prostate, Testicular, and Penile (Video MP4 Format)Genitourinary Cancer-Prostate, Testicular, and Penile (PDF Format)Genomic landscape of angiosarcoma A targeted and immunotherapy biomarker analysis of 143 patients (Video MP4 Format)Genomic testing among patients (pts) with newly diagnosed advanced non-small cell lung cancer (aNSCLC) in the United States (Video MP4 Format)Genomically informed longitudinal monitoring of circulating tumor DNA (ctDNA) to predict outcomes of cancer therapy (Video MP4 Format)Geographic disparity of outcome in patients with cancer over decades The surveillance, epidemiology, and end results (Video MP4 Format)Geriatric assessment-driven intervention (GAIN) on chemotherapy toxicity in older adults with cancer (Video MP4 Format)Geriatric assessment-driven intervention (GAIN) on chemotherapy toxicity in older adults with cancer (PDF Format)Get Up and Go Impact of Geriatric Assessment-Driven Interventions (Video MP4 Format)Get Up and Go Impact of Geriatric Assessment-Driven Interventions (PDF Format)Getting in Early New Frontiers in Palliative Care Interventions (Video MP4 Format)Getting in Early New Frontiers in Palliative Care Interventions (PDF Format)Getting to the Heart of Late Effects (Video MP4 Format)Getting to the Heart of Late Effects (PDF Format)Glasdegib (GLAS) plus low-dose cytarabine (LDAC) in AML or MDS BRIGHT AML 1003 final report and four-year overall survival (OS) follow-up (Video MP4 Format)Glasdegib in combination with azacitidine (AZA) in patients (pts) with untreated higher-risk myelodysplastic syndromes (MDS) (Video MP4 Format)Gls-010, a novel anti-PD-1 mAb in Chinese patients with recurrent or metastatic cervical cancer (Video MP4 Format)Gls-010, a novel anti-PD-1 mAb in Chinese patients with relapsed or refractory classical Hodgkin lymphoma (Video MP4 Format)GO39775 A multicenter phase I trial evaluating the safety, pharmacokinetics, and activity of BFCR4350A (Video MP4 Format)Going Virtual Bringing Genetic Medicine Close to Home (Video MP4 Format)Going Virtual Bringing Genetic Medicine Close to Home (PDF Format)Guest Speaker’s Address (Video MP4 Format)Guns N’ Roses CAR T in Multiple Myeloma (Video MP4 Format)Guns N’ Roses CAR T in Multiple Myeloma (PDF Format)Gynecologic Cancer (Video MP4 Format)Gynecologic Cancer (PDF Format)HANNA Real-world outcomes from an observational study with nivolumab in patients with recurrent (Video MP4 Format)Harness the Immune System for Pediatric Solid Tumors (Video MP4 Format)Harness the Immune System for Pediatric Solid Tumors (PDF Format)Has Cancer MET Its Match (Video MP4 Format)Has Cancer MET Its Match (PDF Format)Head and Neck Cancer Immunity Cycle Challenges and Opportunities (Video MP4 Format)Head and Neck Cancer (Video MP4 Format)Head and Neck Cancer (PDF Format)Health and cancer concerns among siblings of childhood cancer survivors (Video MP4 Format)Health Services Research and Quality Improvement Highlights (Video MP4 Format)Health Services Research and Quality Improvement Highlights (PDF Format)Health-related quality of life (HRQL) in patients with advanced cutaneous squamous cell carcinoma (CSCC) treated with cemiplimab (Video MP4 Format)Health-related quality of life (HRQoL) for olaparib versus enzalutamide or abiraterone in metastatic castration-resistant (Video MP4 Format)Health-related quality of life (HRQoL) in patients with untreated higher-risk myelodysplastic syndromes (MDS) (Video MP4 Format)Hematologic Malignancies – Leukemia, MDS, and Allotransplant (Video MP4 Format)Hematologic Malignancies – Leukemia, MDS, and Allotransplant (PDF Format)Hematologic Malignancies – Lymphoma and CLL (Video MP4 Format)Hematologic Malignancies – Lymphoma and CLL (PDF Format)Hematologic Malignancies – Plasma Cell Dyscrasia (Video MP4 Format)Hematologic Malignancies – Plasma Cell Dyscrasia (PDF Format)Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with unresectable hepatocellular carcinoma (HAIROX) (Video MP4 Format)HER2 status and prediction of extended endocrine benefit with breast cancer index (BCI) in HR+ patients (Video MP4 Format)HERO phase III trial Results comparing relugolix, an oral GnRH receptor antagonist, versus leuprolide acetate for advanced prostate cancer (Video MP4 Format)HERO phase III trial Results comparing relugolix, an oral GnRH receptor antagonist, versus leuprolide acetate for advanced prostate cancer (PDF Format)High amphiregulin mRNA expression is a strong prognostic biomarker with response to cetuximab in FIRE-1, CIOX, and FIRE-3 (Video MP4 Format)High-dose osimertinib for CNS progression in EGFR+ non-small cell lung cancer (NSCLC) (Video MP4 Format)High-dose vitamin D supplementation for cancer-treatment-induced bone loss in 164 breast and prostate cancer patient (Video MP4 Format)High-risk breast cancer genes at 8q22-24 and their role in over 5,000 patients evaluated with the 70-gene risk of recurrence assay (Video MP4 Format)Histopathologic validation of the sentinel node technique in early-stage cervical cancer patients (Video MP4 Format)Histopathologic validation of the sentinel node technique in early-stage cervical cancer patients (PDF Format)Hitting the Bullseye Evolving Role of Targeted and Immune Therapy in Gastroesophageal Cancers (Video MP4 Format)Hitting the Bullseye Evolving Role of Targeted and Immune Therapy in Gastroesophageal Cancers (PDF Format)Home ePRO compliance in prostate cancer clinical studies (Video MP4 Format)Home to Stay! (Video MP4 Format)Home to Stay! (PDF Format)Home-based management of cancer patients (CPs) experiencing toxicities while on anticancer treatment (Video MP4 Format)Home-based management of cancer patients (CPs) experiencing toxicities while on anticancer treatment (PDF Format)Hospitalizations following cancer diagnosis National values for frequency, duration, and charges (Video MP4 Format)HSD3B1 (1245A C) polymorphism and clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients (Video MP4 Format)Hyponatremia could be an important prognostic factor for oncology patients Result of a retrospective study (Video MP4 Format)Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in patients with relapsed (Video MP4 Format)Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in patients with relapsed (PDF Format)Identification of FGFR2 3 fusions from clinical cfDNA NGS using a de novo fusion caller (Video MP4 Format)Identification of pathogenic ROS1 alterations in cell-free DNA (cfDNA) from patients with breast cancer (Video MP4 Format)Identifying and Validating Novel Biomakers in Glioma (Video MP4 Format)Identifying and Validating Novel Biomakers in Glioma (PDF Format)IDH1 mutation detection in plasma circulating tumor DNA (ctDNA) and association with clinical response in patients (Video MP4 Format)IDH-Mutated Low-Grade Glioma An Evolving Landscape (Video MP4 Format)IDH-Mutated Low-Grade Glioma An Evolving Landscape (PDF Format)IGM-8444 as a potent agonistic Death Receptor 5 (DR5) IgM antibody Induction of tumor cytotoxicity, combination (Video MP4 Format)Immediate post-thermal ablation biopsy of colorectal liver metastases to predict oncologic outcomes (Video MP4 Format)Immune functional portraits of head and neck cancer using next generation sequencing (Video MP4 Format)Immune microenvironment profiling of breast cancer brain metastases using multiplex immunofluorescence (Video MP4 Format)Immune profiling and clinical outcomes in patients treated with ramucirumab and pembrolizumab in phase I study JVDF (Video MP4 Format)Immunogenomic characterization of advanced clear cell renal cell carcinoma treated with PD-1 blockade (Video MP4 Format)Immunohistochemical characterization of anaplastic large cell lymphoma using tissue microarray (Video MP4 Format)IMMUNOSARC a collaborative Spanish (GEIS) and Italian (ISG) sarcoma groups phase I II trial of sunitinib (Video MP4 Format)Immunoscore as a parameter predicting time to recurrence and disease-free survival in T4N0 stage II colon cancer patients (Video MP4 Format)Impact of baseline symptom burden as assessed by patient-reported outcomes (PROs) on overall survival (OS) (Video MP4 Format)Impact of body composition on toxicity and pathological complete response in locally advanced breast cancer (BC) (Video MP4 Format)Impact of body measurements (BM) on overall survival (OS) and quality of life (QoL) in real-world patients (pts) (Video MP4 Format)Impact of chemotherapy alone or in combination with an anti-angiogenic on the immune tumor microenvironment (TME) (Video MP4 Format)Impact of chemotherapy alone or in combination with an anti-angiogenic on the immune tumor microenvironment (TME) (PDF Format)Impact of delays in initiation of adjuvant endocrine therapy and survival among patients with breast cancer (Video MP4 Format)Impact of empirically eliminating 5-fluorouracil (5-FU) bolus and leucovorin (LV) in patients with metastatic (Video MP4 Format)Impact of immune checkpoint and BRAF inhibitors on the incidence of second primary malignancies (SPM) in melanoma (Video MP4 Format)Impact of olaparib vs physician’s choice of new hormonal agent (pcNHA) on burden of pain in metastatic castration-resistant (Video MP4 Format)Impact of performance status on response and survival among patients receiving checkpoint inhibitors for advanced solid tumors (Video MP4 Format)Impact of PSMA-targeted imaging with 18F-DCFPyL-PET CT on clinical management of patients (pts) (Video MP4 Format)Impact of PSMA-targeted imaging with 18F-DCFPyL-PET CT on clinical management of patients (pts) (PDF Format)Impact of radiotherapy on risk of adverse events in patients receiving immunotherapy (Video MP4 Format)Impact of relacorilant, a selective glucocorticoid receptor antagonist, on the immunosuppressive effects of endogenous cortisol (Video MP4 Format)Impact of renal impairment on clinical outcomes in patients (pts) with locally advanced or metastatic (LA M) (Video MP4 Format)Impact of SWI SNF complex mutations in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (Video MP4 Format)Implementation issues in screening Do you see me now (Video MP4 Format)Implementation of systematic germline genetic testing (GT) for metastatic prostate cancer (mPC) patients (Video MP4 Format)IMpower150 Exploratory analysis of brain metastases development (Video MP4 Format)Improved prognostication for lung cancer patients from computed tomography imaging using deep learning (Video MP4 Format)Improving cancer pain control Potential impact of CYP2D6 pharmacogenomic (PGx) testing in oncology (Onc) patients (Video MP4 Format)Improving Ewing Sarcoma Therapy Through Front-End and Back-End Chemotherapy Approaches (PDF Format)Improving Our Aim Targeted Therapy Advances in Breast Cancer (Video MP4 Format)Improving Outcomes in Neuroblastoma Cooperating Agents and Cooperating Groups (Video MP4 Format)Improving Outcomes in Neuroblastoma Cooperating Agents and Cooperating Groups (PDF Format)Improving Pediatric Allogenic Transplantation and Survivorship (Video MP4 Format)Improving Pediatric Allogenic Transplantation and Survivorship (PDF Format)IMvigor010 Primary analysis from a phase III randomized study of adjuvant atezolizumab (atezo) versus observation (obs) (Video MP4 Format)IMvigor010 Primary analysis from a phase III randomized study of adjuvant atezolizumab (atezo) versus observation (obs) (PDF Format)In vitro and in vivo characterization of MDNA11 A long-acting ‘beta-only’ IL-2 superkine in syngeneic mice tumor (Video MP4 Format)Incidence of graft versus host disease in peri transplant hospitalization after clostridium difficile infection (Video MP4 Format)Incidence of large granular lymphocytosis (LGL) in patients with late cytopenias after allogeneic blood or marrow transplantation (AlloBMT) (Video MP4 Format)Incidence of PI3K pathway alteration and response to neoadjuvant therapy (NAT) in triple negative breast cancer (Video MP4 Format)Inclusion of economic outcomes in NCI grants A portfolio analysis (Video MP4 Format)Increased pathological complete response rate with neoadjuvant denosumab in locally advanced giant cell tumor (Video MP4 Format)INDIGO A global, randomized, double-blind, phase III study of vorasidenib (VOR; AG-881) vs placebo in patients (pts) (Video MP4 Format)Indirect comparison of TAK-788 vs real-world data outcomes in refractory non-small cell lung cancer (NSCLC) (Video MP4 Format)Individulizing the Adjuvant Approach for the Pancreatic Cancer and Expanding Options in Advanced Pancreatic NETs (Video MP4 Format)INDUCE-1 Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist GSK3359609 (GSK609) (Video MP4 Format)INDUCE-3 A randomized, double-blind study of GSK3359609 (GSK609), an inducible T-cell co-stimulatory (ICOS) (Video MP4 Format)Infigratinib and treatment response in advanced unresectable or metastatic urothelial carcinoma in first-line and later-line (Video MP4 Format)Infiltration of tumor by T cells following treatment with DPX-Survivac and intermittent low dose cyclophosphamide (CPA) (Video MP4 Format)Inflammatory and clinical risk factors for chemotherapy-induced peripheral neuropathy (CIPN) (Video MP4 Format)Influence of antibiotic therapy (ATB) on oncological outcomes of metastatic non-small cell lung cancer (mNSCLC) patients (Video MP4 Format)Influence of BRCA pathogenic variants in the benefit of secondary cytoreductive surgery (Video MP4 Format)Initial correlative studies from a trial of cetuximab and pembrolizumab in metastatic colorectal cancer (mCRC) (Video MP4 Format)Initial experience of the adjuvant treatments to the local tumor for metastatic prostate cancer (Video MP4 Format)Initial results from a phase II study (TACTI-002) in metastatic non-small cell lung or head and neck carcinoma patients (Video MP4 Format)Initial results of a multicenter, investigator initiated study of MRD driven time limited therapy with zanubrutinib (Video MP4 Format)Initial results of a multicenter, investigator initiated study of MRD driven time limited therapy with zanubrutinib (PDF Format)Innovation in Neoadjuvant Therapy (Video MP4 Format)Innovations in Induction Therapy in Non-Small Cell Lung Cancer (Video MP4 Format)INO-5401 and INO-9012 delivered intramuscularly (IM) with electroporation (EP) in combination with cemiplimab (REGN2810) (Video MP4 Format)Integrated geriatric assessment and treatment (INTEGERATE) in older people with cancer planned for systemic anticancer therapy (Video MP4 Format)Integrated geriatric assessment and treatment (INTEGERATE) in older people with cancer planned for systemic anticancer therapy (PDF Format)Integrative tumor and immune cell multi-omic analyses to predict melanoma response to immune checkpoint blockade (Video MP4 Format)Interim analysis (IA) of OPTIC A dose-ranging study of three ponatinib (PON) starting doses (Video MP4 Format)Interim analysis (IA) of OPTIC A dose-ranging study of three ponatinib (PON) starting doses (PDF Format)Interim analysis of ZUMA-5 A phase II study of axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed (Video MP4 Format)Interim analysis of ZUMA-5 A phase II study of axicabtagene ciloleucel (axi-cel) in patients (pts) with relapsed (PDF Format)Intervention combining nurse navigators (NNs) and a mobile application versus standard of care (SOC) in cancer patients (Video MP4 Format)Intervention combining nurse navigators (NNs) and a mobile application versus standard of care (SOC) in cancer patients (PDF Format)Intracranial activity of selpercatinib (LOXO-292) in RET fusion-positive non-small cell lung cancer (NSCLC) patients (Video MP4 Format)Intracranial anti-tumor activity of lazertinib in patients with advanced NSCLC who progressed after prior EGFR TKI therapy (Video MP4 Format)Intra-operative radiation therapy as salvage treatment option for recurrent glioblastoma multiforme (Video MP4 Format)Intratumoral exposure levels of pentaglutamated pemetrexed following treatment with LEAF-1401 and pemetrexed (Video MP4 Format)Intrathoracic versus cervical anastomosis after minimally invasive esophagectomy for esophageal cancer (Video MP4 Format)Investigating Appropriate Dose, Schedule, and Setting of PD-1 and CTLA-4 Blockade (Video MP4 Format)Investigating Appropriate Dose, Schedule, and Setting of PD-1 and CTLA-4 Blockade (PDF Format)Investigating the tumor immune infiltrate for populations that predict immune-related adverse events (irAEs) in patients (Video MP4 Format)IO IO How Far Do We Go (Video MP4 Format)IPAX-1 Phase I II study of 131I-iodo-phenylalanine combined with external radiation therapy as treatment (Video MP4 Format)Ipilimumab (IPI) alone or in combination with anti-PD-1 (IPI+PD1) in patients (pts) with metastatic melanoma (MM) (Video MP4 Format)Ipilimumab (IPI) alone or in combination with anti-PD-1 (IPI+PD1) in patients (pts) with metastatic melanoma (MM) (PDF Format)Ipilimumab challenge re-challenge in metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors treated (Video MP4 Format)Is autologous transplantation (autoHCT) in relapsed diffuse large B-cell lymphoma (DLBCL) patients achieving (Video MP4 Format)Is autologous transplantation (autoHCT) in relapsed diffuse large B-cell lymphoma (DLBCL) patients achieving (PDF Format)Is PSMA Right on Target (Video MP4 Format)Is PSMA Right on Target (PDF Format)It’s All About Access How Resources Affect Who Lives and Dies (Video MP4 Format)It’s Not All Drugs Nonpharmacologic Interventions for Cancer Control (Video MP4 Format)It’s Not All Drugs Nonpharmacologic Interventions for Cancer Control (PDF Format)It’s Not What You Say, It’s How You Say It New Genetic Testing Delivery Models (Video MP4 Format)It’s Not What You Say, It’s How You Say It New Genetic Testing Delivery Models (PDF Format)Ixazomib vs placebo maintenance for newly diagnosed multiple myeloma (NDMM) patients not undergoing (Video MP4 Format)Ixazomib-dexamethasone (Ixa-Dex) vs physician’s choice (PC) in relapsed refractory (RR) primary systemic AL amyloidosis (AL) patients (pts) (Video MP4 Format)Just-in-Time Teaching (JiTT) screencasts for the resident inpatient oncology service (Video MP4 Format)Juvenile granulosa cell tumor An interim report from the international ovarian and testicular stromal tumor (OTST) registry (Video MP4 Format)KarMMa-RW A study of real-world treatment patterns in heavily pretreated patients with relapsed and refractory multiple myeloma (RRMM) (Video MP4 Format)KEAP1 NFE2L2 mutations to predict local recurrence after radiotherapy but not surgery in localized non-small cell lung cancer (Video MP4 Format)KEYNOTE-048 Progression after the next line of therapy following pembrolizumab (P) or P plus chemotherapy (P+C) (Video MP4 Format)KEYNOTE-048 Progression after the next line of therapy following pembrolizumab (P) or P plus chemotherapy (P+C) (PDF Format)KEYNOTE-199 cohorts (C) 4 and 5 Phase II study of pembrolizumab (pembro) plus enzalutamide (enza) (Video MP4 Format)KEYNOTE-204 Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) (Video MP4 Format)KEYNOTE-204 Randomized, open-label, phase III study of pembrolizumab (pembro) versus brentuximab vedotin (BV) (PDF Format)KEYNOTE-355 Randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo (Video MP4 Format)KEYNOTE-355 Randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo (PDF Format)KEYNOTE-604 Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy (Video MP4 Format)KEYNOTE-604 Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy (PDF Format)KITE-439 A phase I study of HPV16 E7 T cell receptor-engineered T cells in patients with relapsed refractory (Video MP4 Format)Large scale clinico-genomic analyses among patients with BRAF-mutated non-small cell lung cancers (NSCLC) (Video MP4 Format)Late toxicities and recurrences in patients with clinical stage I nonseminomatous germ cell tumor after one cycle (Video MP4 Format)Launch prices and price developments of cancer drugs in the United States and Europe (PDF Format)Learning to Juggle Targeted and Immune Therapy Options in Advanced Gastroesophageal Cancers (Video MP4 Format)Lenvatinib plus pembrolizumab combination therapy in patients with radioiodine-refractory (RAIR) (Video MP4 Format)Let’s Get a Move On! (Video MP4 Format)Let’s Get a Move On! (PDF Format)Letrozole + ribociclib versus letrozole + placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial) (Video MP4 Format)Letrozole + ribociclib versus letrozole + placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial) (PDF Format)Leveraging Big Data to Inform Cancer Care Delivery and Policy (PDF Format)Leveraging Biomarkers and Clinical Characteristics to Guide Adjuvant Therapy (Video MP4 Format)Leveraging Biomarkers and Clinical Characteristics to Guide Adjuvant Therapy (PDF Format)Limited-Stage Small Cell Lung Cancer Have We Finally Defined Radiation Standards (Video MP4 Format)Limited-Stage Small Cell Lung Cancer Have We Finally Defined Radiation Standards (PDF Format)Liquid biopsy of the immune environment Evaluation of peripheral blood mononuclear cells (PBMCs) with CyTOF (Video MP4 Format)Liquid Profiling to Inform CDK4-6 Therapy (Video MP4 Format)Liquid Profiling to Inform CDK4-6 Therapy (PDF Format)Lisocabtagene maraleucel (liso-cel) for treatment of second-line (2L) transplant noneligible (TNE) relapsed refractory (R R) (Video MP4 Format)Longitudinal cumulative dose A novel measure to assess multiple dimensions of chemotherapy adherence over time (Video MP4 Format)Long-term benefit of adjuvant dabrafenib + trametinib (D+T) in patients (pts) with resected stage III BRAF V600-mutant melanoma (Video MP4 Format)Long-term benefit of adjuvant dabrafenib + trametinib (D+T) in patients (pts) with resected stage III BRAF V600-mutant melanoma (PDF Format)Long-term cancer survival in cohorts of U.S. health professionals (Video MP4 Format)Long-term financial outcomes and quality of life in partners of colorectal cancer survivors (Video MP4 Format)Long-term follow up of lifileucel (LN-144) cryopreserved autologous tumor infiltrating lymphocyte therapy in patients (Video MP4 Format)Long-term follow up of lifileucel (LN-144) cryopreserved autologous tumor infiltrating lymphocyte therapy in patients (PDF Format)Long-term follow-up assessment of cardiac safety in SAFE-HEaRt, a clinical trial evaluating the use of HER2-targeted therapies (Video MP4 Format)Long-term follow-up for duration of response (DoR) after weekly nab-sirolimus in patients with advanced (Video MP4 Format)Long-term follow-up of anti-CD19 CAR T-cell therapy for B-cell lymphoma and chronic lymphocytic leukemia (Video MP4 Format)Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) (Video MP4 Format)Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) (PDF Format)Long-term immune-related adverse events under PD-1 inhibitors a multicenter prospective cohort study (MELBASE) (Video MP4 Format)Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer (Video MP4 Format)Long-term oncological safety of sentinel lymph node biopsy in early-stage cervical cancer (PDF Format)Long-term responders to PD-1 blockade in patients with advanced non-small cell lung cancer (NSCLC) (Video MP4 Format)Long-term survival from pembrolizumab (pembro) completion and pembro retreatment (Video MP4 Format)Long-term survivors and gilteritinib safety beyond one year in FLT3-mutated R R AML ADMIRAL trial follow-up (Video MP4 Format)Looking Ahead to the Next Generation of Immunotherapy Trials in Sarcoma (Video MP4 Format)Looking Back on COVID in order to Move Forward (Video MP4 Format)Looking Back on COVID in order to Move Forward (PDF Format)Lorlatinib for advanced ALK and ROS1+ non-small cell lung cancer (NSCLC) (Video MP4 Format)Lost in the Woods Seeking Novel Therapies from the Patient’s Perspective (Video MP4 Format)Lost in the Woods Seeking Novel Therapies from the Patient’s Perspective (PDF Format)Low-cost oral metronomic versus intravenous chemotherapy in recurrent, inoperable and metastatic head and neck cancer (Video MP4 Format)Low-cost oral metronomic versus intravenous chemotherapy in recurrent, inoperable and metastatic head and neck cancer (PDF Format)Lower-dosing ponatinib in pre-treated GIST Results of the POETIG phase II trial (Video MP4 Format)Lung Cancer – Non-small Cell Local-regional Small Cell Other (Video MP4 Format)Lung Cancer – Non-small Cell Local-regional Small Cell Other (PDF Format)Lung Cancer – Non-small Cell Metastatic (Video MP4 Format)Lung Cancer – Non-small Cell Metastatic (PDF Format)Lung cancer as a subsequent neoplasm A report from the Childhood Cancer Survivor Study (CCSS) (Video MP4 Format)Lung cancer screening knowledge in four internal medicine university programs (Video MP4 Format)Lurbinectedin (LUR) in combination with Irinotecan (IRI) in patients (pts) with advanced solid tumors – Copy (Video MP4 Format)Lurbinectedin (LUR) in combination with Irinotecan (IRI) in patients (pts) with advanced solid tumors (PDF Format)Machine learning guided adjuvant treatment of head and neck cancer – Copy (Video MP4 Format)Madness in the Method Using Risk Assessment Models Correctly – Copy (Video MP4 Format)Madness in the Method Using Risk Assessment Models Correctly (PDF Format)Maintenance avelumab + best supportive care (BSC) versus BSC alone after platinum-based first-line (1L) (Video MP4 Format)Maintenance avelumab + best supportive care (BSC) versus BSC alone after platinum-based first-line (1L) (PDF Format)Maintenance olaparib plus bevacizumab (bev) after platinum-based chemotherapy plus bev in patients (pts) (Video MP4 Format)Maintenance oral etoposide (VP-16) after high-dose chemotherapy (HDCT) for patients with relapsed metastatic germ-cell tumors (mGCT) (Video MP4 Format)Maintenance therapy with oral cyclophosphamide plus celecoxib in patients with metastatic Ewing sarcoma (Video MP4 Format)Maintenance therapy with oral cyclophosphamide plus celecoxib in patients with metastatic Ewing sarcoma (PDF Format)Mammography adherence among medically underserved women undergoing cancer genetic risk assessment (Video MP4 Format)Mammography utilization among women with a negative circulating tumor DNA-based early cancer detection test (Video MP4 Format)Man Versus Machine Is Artificial Intelligence Ready for Clinical Practice (Video MP4 Format)Man Versus Machine Is Artificial Intelligence Ready for Clinical Practice (PDF Format)Management of adverse events in patients with HER2+ metastatic breast cancer treated with tucatinib (Video MP4 Format)Mantle cell lymphoma initial report from the North American Mantle Cell Lymphoma Consortium (Video MP4 Format)Maximizing Benefit Through Biomarker-Directed Therapy (Video MP4 Format)Maximizing Benefit Through Biomarker-Directed Therapy (PDF Format)Maximizing the Benefits of Targeted Therapies (Video MP4 Format)Maximizing the Benefits of Targeted Therapies (PDF Format)MDNA55 survival in recurrent glioblastoma (rGBM) patients expressing the interleukin–4 receptor (IL4R) (Video MP4 Format)Measurable residual disease (MRD) assessed by mass spectrometry (MS) in peripheral blood versus next generation (Video MP4 Format)MEeT the Professor Where Do We Go Now (Video MP4 Format)MEeT the Professor Where Do We Go Now (PDF Format)Meeting the Needs of Patients With Advanced Cancer Systems Approaches to Palliative Care Delivery (Video MP4 Format)Meeting the unMET Need! (Video MP4 Format)Meeting the unMET Need! (PDF Format)Melanoma Skin Cancers (Video MP4 Format)Melanoma Skin Cancers (PDF Format)Meta-analysis of cyclin-dependent kinase (CDK) 4 6 inhibitors with endocrine therapy versus endocrine (Video MP4 Format)Metabolic syndrome, metabolic comorbid conditions, and risk of early-onset colorectal cancer (Video MP4 Format)Methodology, results, and publication of oncology clinical trials Insights from all the world’s randomized (Video MP4 Format)Mind the Gap Identifying Disparities and Actionable Insights (Video MP4 Format)Mind the Gap Identifying Disparities and Actionable Insights (PDF Format)MINDACT Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance (Video MP4 Format)MINDACT Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance (PDF Format)Mirvetuximab soravtansine, a folate receptor alpha (FRà)-targeting antibody-drug conjugate (ADC), in combination (Video MP4 Format)Mirvetuximab soravtansine, a folate receptor alpha (FRà)-targeting antibody-drug conjugate (ADC), in combination (PDF Format)Mismatch between mortality burden and number of FDA registration trials in highly lethal cancers (Video MP4 Format)MiST1 A phase IIa trial of rucaparib in patients harbouring BAP1 BRCA1 deficient relapsed malignant mesothelioma (Video MP4 Format)Mobile apps Breaking barriers to early cancer detection in underserved communities (Video MP4 Format)Model to predict brain metastasis (BM) in patients with metastatic germ-cell tumors (mGCT) (Video MP4 Format)Modulation of inhibitory signals in CAR T cells leads to improved activity against glioblastoma (Video MP4 Format)Molecular determinants of outcome for metastatic castration-sensitive prostate cancer (mCSPC) with addition of apalutamide (APA) (Video MP4 Format)Molecular determinants of prostate specific antigen (PSA) kinetics and clinical response to apalutamide (APA) in patients (pts) (Video MP4 Format)Molecular diagnostic testing patterns in patients (pts) with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) (Video MP4 Format)MONARCH 2 subgroup analysis of patients receiving abemaciclib + fulvestrant as first- and second-line therapy (Video MP4 Format)Morbidity Associated With Cancer Screening and Treatment A Radiation Oncologist Perspective (Video MP4 Format)Morbidity Associated With Cancer Screening and Treatment A Radiation Oncologist Perspective (PDF Format)Moving Beyond the Standard Treatment for Biliary Tract and Hepatocellular Cancers (Video MP4 Format)Moving Beyond the Standard Treatment for Biliary Tract and Hepatocellular Cancers (PDF Format)Moving Closer to Less Progress in De-escalation After Resection (Video MP4 Format)Moving the Bar Innovative Agents for Advanced Hepatocellular Carcinoma (Video MP4 Format)Moving the Needle in High-Risk Lymphoma (Video MP4 Format)Multicentre randomized phase II trial of olaparib as maintenance therapy in platinum-sensitive advanced endometrial carcinoma (Video MP4 Format)Multi-institutional comparative effectiveness of advanced cancer longitudinal imaging response evaluation methods (Video MP4 Format)Multinational Collaboration Paves the Way to Randomized Trials in Ewing Sarcoma (Video MP4 Format)Multinational Collaboration Paves the Way to Randomized Trials in Ewing Sarcoma (PDF Format)Multi-omics analysis of mantle cell lymphoma reveals an immune-cold tumor microenvironment associated with ibrutinib resistance (Video MP4 Format)Multiple myeloma (MM) vaccination (influenza, FV and pneumococcal, PV) rates worldwide and impact on infection, hospitalization, and death (Video MP4 Format)Multisite randomized trial of integrated palliative and oncology care for patients with acute myeloid leukemia (AML) (Video MP4 Format)Multisite randomized trial of integrated palliative and oncology care for patients with acute myeloid leukemia (AML) (PDF Format)Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (Video MP4 Format)Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central (Video MP4 Format)Myelodysplastic syndrome survival and secondary AML trends in the United States (Video MP4 Format)Myeloid Disorders The What and the Why of Treatment (Video MP4 Format)Myeloid Disorders The What and the Why of Treatment (PDF Format)Nano-enabled Medicine (Video MP4 Format)Nano-enabled Medicine (PDF Format)NAPOLI-3 An open-label, randomized, phase III study of first-line liposomal irinotecan + 5-fluorouracil (Video MP4 Format)NEJ026 Final overall survival analysis of bevacizumab plus erlotinib treatment for NSCLC patients harboring activating EGFR-mutations (Video MP4 Format)NEJ026 Final overall survival analysis of bevacizumab plus erlotinib treatment for NSCLC patients harboring activating EGFR-mutations (PDF Format)Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC) (Video MP4 Format)Neoadjuvant apalutamide (APA) plus leuprolide (LHRHa) with or without abiraterone (AA) in localized high-risk prostate cancer (LHRPC) (PDF Format)Neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer (LARC) with or without oxaliplatin (OX) (Video MP4 Format)Neoadjuvant treatment with chemotherapy or chemoradiation in stage III non-small cell lung cancer (Video MP4 Format)Neuroleptic rotation for refractory agitation in cancer patients with delirium in the acute palliative care unit (Video MP4 Format)Neuroleptic rotation for refractory agitation in cancer patients with delirium in the acute palliative care unit (PDF Format)Neuromuscular dysfunction and associated health socioeconomic outcomes (Video MP4 Format)New and Updated Pivotal Trials of Single Agent and Combination Immunocheckpoint Blockers in Bladder and Kidney Cancers (Video MP4 Format)New and Updated Pivotal Trials of Single Agent and Combination Immunocheckpoint Blockers in Bladder and Kidney Cancers (PDF Format)New Antibodies, New Targets Are We Making Progress (Video MP4 Format)New Antibodies, New Targets Are We Making Progress (PDF Format)New Combinations in Endometrial Cancer….Finally! (Video MP4 Format)New Combinations in Endometrial Cancer….Finally! (PDF Format)New Kids on the Block (NKOTB) Novel Therapies in Multiple Myeloma (Video MP4 Format)New Kids on the Block (NKOTB) Novel Therapies in Multiple Myeloma (PDF Format)New Options for Advanced Sarcomas (Video MP4 Format)New Options for Advanced Sarcomas (PDF Format)Nickel and dimed Parking fees at NCI-designated cancer centers (Video MP4 Format)Nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs) (Video MP4 Format)Niraparib exposure-response relationship in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) (Video MP4 Format)NIVACOR Phase II study of nivolumab in combination with FOLFOXIRI bevacizumab in first-line chemotherapy (Video MP4 Format)NivoCUP An open-label phase II study on the efficacy of nivolumab in cancer of unknown primary (Video MP4 Format)NivoCUP An open-label phase II study on the efficacy of nivolumab in cancer of unknown primary (PDF Format)Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) (Video MP4 Format)Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) (PDF Format)Nivolumab (NIVO) + low-dose ipilimumab (IPI) as first-line (1L) therapy in microsatellite instability-high (Video MP4 Format)Nivolumab (NIVO) plus ipilimumab (IPI) with two cycles of chemotherapy (chemo) in first-line metastatic (Video MP4 Format)Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer (Video MP4 Format)Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer (PDF Format)Nivolumab and brentuximab vedotin (BV)-based, response-adapted treatment in children, adolescents, and young adults (CAYA) (Video MP4 Format)NOMINATOR Feasibility of genomic testing of rare cancers to match cancer to treatment (Video MP4 Format)NOMINATOR Feasibility of genomic testing of rare cancers to match cancer to treatment (PDF Format)Non-invasive detection of urothelial carcinoma (UC) by cost-effective low-coverage whole genome sequencing (Video MP4 Format)Noninvasive identification of lineage-specific circular RNA for ER-positive breast cancer (Video MP4 Format)Non-pneumonitis immune-mediated adverse events (imAEs) with durvalumab in patients with unresectable stage III NSCLC (PACIFIC) (Video MP4 Format)Novel Antimitotic Drug Delivery and Combination Strategies (Video MP4 Format)Novel Antimitotic Drug Delivery and Combination Strategies (PDF Format)Novel Approaches to Optimizing Immune Checkpoint Inhibitors (Video MP4 Format)Novel Approaches to Optimizing Immune Checkpoint Inhibitors (PDF Format)Novel biomarker panel based on cellular and soluble checkpoint proteins for PD-1 PD-L1 blockade treatment efficacy (Video MP4 Format)Novel Biomarkers in Prostate Cancer Is the Tissue the Issue (Video MP4 Format)Novel Biomarkers in Prostate Cancer Is the Tissue the Issue (PDF Format)Novel estrogen receptor beta agonist S-equol decreases tumor proliferation in patients with triple negative (Video MP4 Format)Novel Immunotherapy Delivery Strategies Sticking It to the Tumor (Video MP4 Format)Novel Immunotherapy Strategies (Video MP4 Format)Novel Immunotherapy-Based Therapy in Metastatic Urothelial Cancers (Video MP4 Format)Novel Inductions in Acute Myeloid Leukemia in Older Patients Did Longer Follow-up Provide Us Unique Insights (Video MP4 Format)Novel Inductions in Acute Myeloid Leukemia in Older Patients Did Longer Follow-up Provide Us Unique Insights (PDF Format)Novel methylated DNA markers in plasma detect distant recurrence of colorectal cancer (Video MP4 Format)Novel Targeted Therapy Approaches (Video MP4 Format)Novel Targeted Therapy Approaches (PDF Format)Novel Targets and Combinations for Refractory Solid Tumors (Video MP4 Format)Novel Targets and Combinations for Refractory Solid Tumors (PDF Format)NSCLC Integrating the ‘Yale model shared decision-making solution’ into the practice setting (Video MP4 Format)Nurturing an Orphan Drug (Video MP4 Format)Nurturing an Orphan Drug (PDF Format)Obstetrical and perinatal complications in survivors of childhood, adolescent, and young adult cancer (Video MP4 Format)Of Bugs and Drugs How Our Microbiome Saves Us (Video MP4 Format)Olaparib (O) in patients (pts) with pancreatic cancer with BRCA1 2 inactivating mutations (Video MP4 Format)Olaparib (O) in patients (pts) with prostate cancer with BRCA1 2 inactivating mutations (Video MP4 Format)Olaparib maintenance monotherapy for non-germline BRCA1 2-mutated (non-gBRCAm) platinum-sensitive relapsed (Video MP4 Format)Olaparib sensitivity observed in metastatic pancreatic cancer (mPaC) with a wide spectrum of germline BRCA1 and BRCA2 (Video MP4 Format)Olaparib treatment in patients (pts) with platinum-sensitive relapsed (PSR) ovarian cancer (OC) by BRCA mutation (BRCAm) (Video MP4 Format)ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG (Video MP4 Format)Once weekly selinexor, carfilzomib, and dexamethasone (SKd) in patients with relapsed refractory multiple myeloma (MM) (Video MP4 Format)Oncogeriatric Prehab Optimizing Older Adults for Cancer Treatment (Video MP4 Format)Oncogeriatric Prehab Optimizing Older Adults for Cancer Treatment (PDF Format)Oncological outcomes of 356 patients undergoing salvage focal ablative HIFU or cryotherapy following radiation failure (Video MP4 Format)One Size Does Not Fit ALL Modifiers of Response and Toxicity (Video MP4 Format)Ongoing, first-in-human, phase I dose escalation study of the investigational CD47-blocker TTI-622 in patients (Video MP4 Format)Opening Remarks (Video MP4 Format)Opening Remarks (PDF Format)Open-label pilot study of genetically engineered NY-ESO-1-specific t cells (GSK3377794) alone or in combination (Video MP4 Format)Optimal Management and Monitoring of Primary Germ Cell Tumors of the Central Nervous System (Video MP4 Format)Optimal Management and Monitoring of Primary Germ Cell Tumors of the Central Nervous System (PDF Format)Optimized management of nivolumab (Nivo) and ipilimumab (Ipi) in advanced renal cell carcinoma (RCC) (Video MP4 Format)Optimized management of nivolumab (Nivo) and ipilimumab (Ipi) in advanced renal cell carcinoma (RCC) (PDF Format)Optimizing Imaging to Predict Glioblastoma Outcomes (Video MP4 Format)Optimizing Imaging to Predict Glioblastoma Outcomes (PDF Format)Oral DNA vaccination targeting VEGFR2 combined with anti-PDL1 avelumab in patients with progressive glioblastoma (PDF Format)Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) (Video MP4 Format)Orvacabtagene autoleucel (orva-cel), a B-cell maturation antigen (BCMA)-directed CAR T cell therapy for patients (pts) (PDF Format)Osimertinib as adjuvant therapy in patients (pts) with stage IB-IIIA EGFR mutation positive (EGFRm) NSCLC (Video MP4 Format)Osimertinib as adjuvant therapy in patients (pts) with stage IB-IIIA EGFR mutation positive (EGFRm) NSCLC (PDF Format)Osimertinib in non-small cell lung cancer (NSCLC) with atypical EGFR activating mutations (Video MP4 Format)Outcome in patients with refractory high-risk neuroblastoma (Video MP4 Format)Outcomes and prognostic factors of patients (pts) with metastatic colorectal cancer (mCRC) who underwent (Video MP4 Format)Outcomes and the impact of genomic characteristics on patients with metastatic urothelial carcinoma enrolled in early phase trials (Video MP4 Format)Outcomes for black versus white women with stage IV breast cancer enrolled on investigator-initiated clinical trials at Emory (Video MP4 Format)Outcomes in children with Down syndrome (DS) and B-lymphoblastic leukemia (B-ALL) (Video MP4 Format)Outcomes in children with Down syndrome (DS) and B-lymphoblastic leukemia (B-ALL) (PDF Format)Outcomes in older patients with high-risk secondary AML who achieved remission with CPX-351 versus 7+3 but (Video MP4 Format)Outcomes of patients (pts) with metastatic urothelial carcinoma (mUC) following discontinuation of enfortumab-vedotin (EV) (Video MP4 Format)Outcomes with reduced intensity therapy in a low-risk subset of children with National Cancer Institute (NCI) (Video MP4 Format)Outcomes with reduced intensity therapy in a low-risk subset of children with National Cancer Institute (NCI) (PDF Format)Out-of-pocket cost of screening with breast MRI for women at high risk for breast cancer (Video MP4 Format)Outpatient treatment with lisocabtagene maraleucel (liso-cel) across a variety of clinical sites from three ongoing (Video MP4 Format)Ovarian Cancer Hot, Timely, and Painless (Video MP4 Format)Ovarian Cancer Hot, Timely, and Painless (PDF Format)Overall survival (OS) and long-term disease-free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin (Video MP4 Format)Overall survival (OS) and long-term disease-free survival (DFS) of three versus six months of adjuvant (adj) oxaliplatin (PDF Format)Overall survival (OS) in patients (pts) with advanced breast cancer (ABC) with visceral metastases (mets) (Video MP4 Format)Overall survival (OS) results of phase III ARAMIS study of darolutamide (DARO) added to androgen deprivation therapy (ADT) (Video MP4 Format)Overall survival (OS) with docetaxel (D) vs novel hormonal therapy (NHT) with abiraterone (A) or enzalutamide (E) (Video MP4 Format)Overall survival after 177Lu-PSMA-617 molecular radiotherapy in patients with metastatic castrate-resistant prostate cancer (Video MP4 Format)Overall survival and biomarker analysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb (Video MP4 Format)Overall survival and biomarker analysis of a phase Ib combination study of toripalimab, a humanized IgG4 mAb (PDF Format)Pain progression at initiation of cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) is associated with a poor prognosis (Video MP4 Format)PANasta Trial Cattell Warren versus Blumgart techniques of pancreatico-jejunostomy following pancreato-duodenectomy (Video MP4 Format)Pan-cancer analysis of FGFR1-3 genomic alterations to reveal a complex molecular landscape (Video MP4 Format)Panel-based methodology for assessing the impact of public policies on cancer patients and survivors (Video MP4 Format)PARSIFAL A randomized, multicenter, open-label, phase II trial to evaluate palbociclib in combination with fulvestrant (Video MP4 Format)PARSIFAL A randomized, multicenter, open-label, phase II trial to evaluate palbociclib in combination with fulvestrant (PDF Format)Patient-reported care satisfaction and symptom burden in hospitalized patients with cancer (Video MP4 Format)Patient-reported distress and healthcare utilization in patients with advanced cancer (Video MP4 Format)Patient-reported health literacy and numeracy among new patients seeking consultation at a comprehensive cancer center (Video MP4 Format)Patient-reported outcomes (PROs) in the randomized, phase III IMpower110 study of atezolizumab (atezo) (Video MP4 Format)Patient-reported out-of-pocket costs and financial toxicity during early-phase oncology clinical trials (Video MP4 Format)Pazopanib (PZ) plus endocrine therapy as treatment for hormone resistant advanced breast cancer (ABC) (Video MP4 Format)PCR-based comprehensive genomic profiling (PCR-CGP) Feasibility from 20,000 tumor tissue specimens (TTS) (Video MP4 Format)PD-1 protein and gene expression in early breast cancer Prognostic implications (Video MP4 Format)PD-1 Treatment Outcomes Informed by Gene Expression Profiles (Video MP4 Format)PD-1 Treatment Outcomes Informed by Gene Expression Profiles (PDF Format)PDIGREE An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) (Video MP4 Format)PD-L1 positive esophagogastric (EG) cancer is associated with distinct bacteria (Video MP4 Format)PD-L1 tumor proportion score and clinical benefit from first-line pembrolizumab in patients with advanced nonsquamous (Video MP4 Format)‘Pearls’ for Newly Diagnosed High-Risk Multiple Myeloma Finding the Right ‘Jam’ (Video MP4 Format)‘Pearls’ for Newly Diagnosed High-Risk Multiple Myeloma Finding the Right ‘Jam’ (PDF Format)Pediatric Oncology (Video MP4 Format)Pediatric Oncology (PDF Format)Pediatric Precision Oncology 2020 (Video MP4 Format)Pediatric Precision Oncology 2020 (PDF Format)Pembrolizumab (Pem) in combination with stereotactic body radiotherapy (SBRT) for resectable liver oligometastatic MSS (Video MP4 Format)Pembrolizumab (pembro) plus docetaxel and prednisone in patients (pts) with abiraterone acetate (abi) (Video MP4 Format)Pembrolizumab (pembro) plus enzalutamide (enza) in patients (pts) with abiraterone acetate (abi)-pretreated metastatic (Video MP4 Format)Pembrolizumab (pembro) versus standard of care chemotherapy (chemo) in patients with advanced gastric (Video MP4 Format)Pembrolizumab for previously treated advanced anal squamous cell carcinoma Pooled results from the KEYNOTE-028 (Video MP4 Format)Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (Video MP4 Format)Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced renal cell carcinoma (RCC) (PDF Format)Pembrolizumab versus chemotherapy for microsatellite instability-high mismatch repair deficient metastatic (Video MP4 Format)Pembrolizumab versus chemotherapy for microsatellite instability-high mismatch repair deficient metastatic (PDF Format)Pembrolizumab versus paclitaxel for previously treated patients with PD-L1-positive advanced gastric or gastroesophageal (Video MP4 Format)Pembrolizumab versus paclitaxel for previously treated patients with PD-L1-positive advanced gastric or gastroesophageal (PDF Format)Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma (Video MP4 Format)Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma (PDF Format)Pembrolizumab with trastuzumab and chemotherapy (PTC) in HER2-positive metastatic esophagogastric cancer (mEG) (Video MP4 Format)Pen-866, a miniature drug conjugate of a heat shock protein 90 (HSP90) ligand linked to SN38 for patients (Video MP4 Format)Performance of the IBIS Tyrer-Cuzick (TC) Model by race ethnicity in the Women’s Health Initiative (Video MP4 Format)Performance of the IBIS Tyrer-Cuzick (TC) Model by race ethnicity in the Women’s Health Initiative (PDF Format)Perioperative circulating tumor DNA analysis to predict patient prognosis in liver cancer (Video MP4 Format)Perioperative chemotherapy versus adjuvant chemoradiation in resectable gastric cancer A national cancer database analysis (Video MP4 Format)Perioperative Novel Systemic Immunotherapy-Based Approaches in Urinary Cancers (Video MP4 Format)Perioperative Novel Systemic Immunotherapy-Based Approaches in Urinary Cancers (PDF Format)Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric adenocarcinoma (PDF Format)Perioperative ramucirumab in combination with FLOT versus FLOT alone for resectable esophagogastric (Video MP4 Format)Perioperative Therapy in Soft Tissue Sarcomas The Debate Continues (Video MP4 Format)Perioperative Therapy in Soft Tissue Sarcomas The Debate Continues (PDF Format)Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable (Video MP4 Format)Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable (PDF Format)Peripheral blood immune correlates associated with TGF-á inhibition (galunisertib) and stereotactic body radiotherapy (SBRT) (Video MP4 Format)Peripheral motor and sensory neuropathy in survivors of childhood central nervous system (CNS) tumors (Video MP4 Format)Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA) Secondary and final primary efficacy analyses (Video MP4 Format)PIK3CA mutation status and progression-free survival in advanced hormone receptor positive (HR+) (Video MP4 Format)Pilot study on outcome and antitumor efficacy of an autologous cancer cell vaccine applied in patients with advanced solid tumors (Video MP4 Format)Pilot study on outcome and antitumor efficacy of an autologous cancer cell vaccine applied in patients with advanced solid tumors (PDF Format)Pivotal DREAMM-2 study Single-agent belantamab mafodotin (GSK2857916) in patients with relapsed (Video MP4 Format)Pivotal trial endpoints and prices of cancer drugs in the US and Europe (Video MP4 Format)Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated (Video MP4 Format)Plasma-based tumor mutational burden (bTMB) as predictor for survival in phase III EAGLE study (Video MP4 Format)Plasma-based tumor mutational burden (bTMB) as predictor for survival in phase III EAGLE study (PDF Format)Plasma-derived cfDNA to reveal potential biomarkers of response prediction and monitoring in non-small cell lung cancer (Video MP4 Format)Platform comparison of HTG EdgeSeq and RNA-Seq for gene expression profiling of tumor tissue specimens (Video MP4 Format)POLARGO Randomized Phase III study of polatuzumab vedotin plus rituximab, gemcitabine, and oxaliplatin (R-GemOx) (Video MP4 Format)POLO Quality-adjusted (QA) progression-free survival (PFS) and patient (pt)-centered outcomes with maintenance olaparib (Video MP4 Format)Pooled ctDNA analysis of the MONALEESA (ML) phase III advanced breast cancer (ABC) trials (Video MP4 Format)Pooled ctDNA analysis of the MONALEESA (ML) phase III advanced breast cancer (ABC) trials (PDF Format)Population genetic screening for hereditary breast and ovarian cancer in at-risk patients (Video MP4 Format)Population-adjusted indirect treatment comparison (PAITC) of maintenance PARP inhibitor (PARPi) with or without (Video MP4 Format)Population-based prostate cancer screening using a prospective, blinded, paired screen-positive comparison of PSA and fast MRI (Video MP4 Format)Post-hoc power of clinical trials supporting anticancer drug approval by FDA (Video MP4 Format)Post-marketing safety surveillance of tumor treating fields (TTFields) in patients with high-grade glioma in clinical practice (Video MP4 Format)Post-traumatic stress symptoms in hematopoietic stem cell transplant (HCT) recipients (Video MP4 Format)Post-traumatic stress symptoms in hematopoietic stem cell transplant (HCT) recipients (PDF Format)Potential germline findings identified during somatic tumor testing Room for improvement (Video MP4 Format)Practice gaps and challenges integrating new immuno-oncology agents in the treatment of cancer patients in the United States (Video MP4 Format)PrE0505 Phase II multicenter study of anti-PD-L1, durvalumab, in combination with cisplatin and pemetrexed (Video MP4 Format)PrE0505 Phase II multicenter study of anti-PD-L1, durvalumab, in combination with cisplatin and pemetrexed (PDF Format)Precision Pounds Poison Promise and Progress (Video MP4 Format)Preclinical evaluation of KZR-261, a novel small molecule inhibitor of Sec61 (Video MP4 Format)Prediabetes and progression to diabetes among adult survivors of childhood cancer in the St. Jude Lifetime Cohort (Video MP4 Format)Predicting nodal positivity in women with hormone receptor-positive (HR+), early stage breast cancer (ESBC) (Video MP4 Format)Prediction of the molecular status in non-small cell lung cancer based on metastatic pattern (Video MP4 Format)Prediction of watchful waiting in newly diagnosed metastatic clear cell renal cell carcinoma patients with a good or intermediate prognosis (Video MP4 Format)Predictive survival ability of patient-reported in comparison to physician-reported performance status in solid malignancies (Video MP4 Format)Predictive value of a CLIA-approved organoid based drug sensitivity test (Video MP4 Format)Predictor of trastuzumab-induced cardiotoxicity in breast cancer (BC) patients (Video MP4 Format)Preliminary activity of tipifarnib in tumors of the head and neck, salivary gland and urothelial tract with HRAS mutations (Video MP4 Format)Preliminary activity of tipifarnib in tumors of the head and neck, salivary gland and urothelial tract with HRAS mutations (PDF Format)Preliminary clinical pharmacokinetics and dose-response to support a phase II dose selection for CX-2009 (Video MP4 Format)Preliminary dose escalation results from a phase I II, first-in-human study of MGC018 (anti-B7-H3 antibody-drug conjugate) (Video MP4 Format)Preliminary efficacy data of platinum-pretreated small cell lung cancer (SCLC) cohort of NCI 9881 study (Video MP4 Format)Preliminary efficacy data of triple-negative breast cancer cohort of NCI 9881 study (Video MP4 Format)Preliminary population pharmacokinetics supports phase II dose selection for masked anti-PD-L1 antibody CX-072 (Video MP4 Format)Preliminary results of a phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated (Video MP4 Format)Preliminary results of a phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated (PDF Format)Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial (Video MP4 Format)Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial (PDF Format)Preliminary safety, efficacy and pharmacokinetics (PK) results of KN026, a HER2 bispecific antibody in patients (pts) (Video MP4 Format)President’s Address (Video MP4 Format)Prevalence and tissue concordance of BRCA2 copy number loss evaluated by single-cell, shallow whole genome (Video MP4 Format)Prevalence of autoimmune diseases in thymic epithelial tumors (TET) insights from RYTHMIC (Video MP4 Format)Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus (Video MP4 Format)Primary analysis of a randomized, double-blind, phase II study of the anti-TIGIT antibody tiragolumab (tira) plus (PDF Format)Primary analysis of KAITLIN A phase III study of trastuzumab emtansine (T-DM1) + pertuzumab versus trastuzumab (Video MP4 Format)Primary analysis of KAITLIN A phase III study of trastuzumab emtansine (T-DM1) + pertuzumab versus trastuzumab (PDF Format)Primary analysis of the randomized phase II trial of bortezomib, lenalidomide, dexamthasone (Video MP4 Format)Primary analysis of the randomized phase II trial of bortezomib, lenalidomide, dexamthasone (PDF Format)Primary Central Nervous System Lymphoma Is There an Optimal First-Line Treatment (Video MP4 Format)Primary cytoreductive surgery with or without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for FIGO stage III (Video MP4 Format)Primary efficacy and biomarker analyses from the VISION study of tepotinib in patients (pts) with non-small cell lung cancer (Video MP4 Format)Primary results of NRG Oncology NSABP B-43 Phase III trial comparing concurrent trastuzumab (T) and radiation therapy (RT) (Video MP4 Format)Primary results of NRG Oncology NSABP B-43 Phase III trial comparing concurrent trastuzumab (T) and radiation therapy (RT) (PDF Format)Prior authorization process improvement for pain medications in an oncology unit Timely initiation of test claim request form (Video MP4 Format)ProCAID A randomized double-blind phase II clinical trial of capivasertib (C) in combination with docetaxel (Video MP4 Format)PROCLAIM-CX-072 Analysis of patients with advanced solid tumors receiving long-term treatment with CX-072 (Video MP4 Format)PROCLAIM-CX-072 Analysis of patients with advanced solid tumors receiving long-term treatment with CX-072 (PDF Format)Product characteristics and pharmacological profile of KTE-X19 in patients (pts) with relapsed refractory (R R) (Video MP4 Format)Prognostic and predictive effects of circulating and disseminated tumor cells in breast cancer (Video MP4 Format)Prognostic differences of RAS mutations Results from South Australian (SA) metastatic colorectal (mCRC) registry (Video MP4 Format)Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib (Video MP4 Format)Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib (PDF Format)Prognostic role of pre-treatment magnetic resonance imaging (MRI) radiomic analysis in patients with squamous cell (Video MP4 Format)Project facilitate A review of the FDA oncology center of excellence expanded access pilot program (Video MP4 Format)Projection of cancer incidence and death to 2040 in the US Impact of cancer screening and a changing demographic (Video MP4 Format)Promising Therapeutic Targets in Prostate Cancer (Video MP4 Format)PROREPAIR-A Clinical and molecular characterization study of prostate cancer (PC) patients (Video MP4 Format)Prospective study comparing self-administered geriatric assessment to provider’s routine clinical assessment of older patients (Video MP4 Format)Prospective study of an AI enabled online intervention to increase delivery of guideline compliant cancer care (Video MP4 Format)Prostate cancer relative survival by stage and race ethnicity, United States, 2001 to 2015 (Video MP4 Format)Prostate-specific antigen (PSA) kinetics in patients (pts) with advanced prostate cancer treated with apalutamide (Video MP4 Format)Proteomic profiling to identify therapeutics targets in glioblastoma (GBM) (Video MP4 Format)Psychosocial outcomes following surgery in women with unilateral, nonhereditary breast cancer (Video MP4 Format)Putting Circulating Tumor DNA to Work Patient Selection for Targeted Therapies and Monitoring of Response and Resistance (Video MP4 Format)Putting Circulating Tumor DNA to Work Patient Selection for Targeted Therapies and Monitoring of Response and Resistance (PDF Format)Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE) A randomized phase III trial (Video MP4 Format)Pyrotinib or lapatinib plus capecitabine for HER2+ metastatic breast cancer (PHOEBE) A randomized phase III trial (PDF Format)Pharmacodynamic (PD) responses drive dose schedule selection of CC-92480, a novel CELMoD agent (Video MP4 Format)Pharmacodynamic, safety, and efficacy results of a phase I II trial of intratumoral INT230-6 alone (IT-01) or in (Video MP4 Format)Pharmacokinetics and safety following a single oral dose of niraparib in patients with moderate hepatic impairment (Video MP4 Format)Phase I Alexander study of AUTO3, the first CD19 22 dual targeting CAR T cell therapy, with pembrolizumab (Video MP4 Format)Phase I Alexander study of AUTO3, the first CD19 22 dual targeting CAR T cell therapy, with pembrolizumab (PDF Format)Phase I clinical trials as a therapeutic option for patients with metastatic renal cell carcinoma (mRCC) (Video MP4 Format)Phase I dose escalation and expansion trial to assess the safety and efficacy of ADP-A2M4 SPEAR T cells in advanced solid tumors (Video MP4 Format)Phase I dose escalation and expansion trial to assess the safety and efficacy of ADP-A2M4 SPEAR T cells in advanced solid tumors (PDF Format)Phase I dose-escalation study of PSMA-targeted alpha emitter 225Ac-J591 in men with metastatic castration (Video MP4 Format)Phase I expansion study of cabozantinib plus nivolumab (CaboNivo) in metastatic urothelial carcinoma (mUC) patients (pts) (Video MP4 Format)Phase I expansion study of XMT-1536, a novel NaPi2b-targeting antibody-drug conjugate (ADC) (Video MP4 Format)Phase I II open label nonrandomized safety and efficacy study of the viral vectored ChAdOx1-MVA 5T4 immunotherapy (Video MP4 Format)Phase I II study of avadomide (CC-122) in combination with R-CHOP for newly diagnosed DLBCL (Video MP4 Format)Phase I II study of avadomide (CC-122) in combination with R-CHOP for newly diagnosed DLBCL (PDF Format)Phase I II study of R-ICE (rituximab-ifosfamide-carboplatin-etoposide) with lenalidomide (R2-ICE) in patients with first-relapse (Video MP4 Format)Phase I II study of SAR439859, an oral selective estrogen receptor degrader (SERD) (Video MP4 Format)Phase I II study of T-DM1 alone versus T-DM1 and metronomic temozolomide in secondary prevention of (Video MP4 Format)Phase I II study to evaluate the safety and clinical efficacy of atezolizumab (atezo; aPDL1) in combination (Video MP4 Format)Phase I monotherapy dose escalation of RGX-202, a first-in-class oral inhibitor of the SLC6a8 CKB pathway (Video MP4 Format)Phase I monotherapy dose escalation of RGX-202, a first-in-class oral inhibitor of the SLC6a8 CKB pathway (PDF Format)Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3á) inhibitor (Video MP4 Format)Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3á) inhibitor (PDF Format)Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration (Video MP4 Format)Phase I study of AMG 160, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting (Video MP4 Format)Phase I study of AMG 509, a STEAP1 x CD3 T cell-recruiting XmAb 2+1 immune therapy, in patients with metastatic (Video MP4 Format)Phase I study of AMG 757, a half-life extended bispecific T-cell engager (HLE BiTE immune therapy) targeting DLL3 (Video MP4 Format)Phase I study of BPM31510 and vitamin K in patients with high grade glioma recurrent after a bevacizumab-containing (Video MP4 Format)Phase I study of IM156, a novel potent biguanide oxidative phosphorylation (OXPHOS) inhibitor, in patients (Video MP4 Format)Phase I study of mesothelin-targeted immunotoxin LMB-100 given as a long infusion with or without nab-paclitaxel (Video MP4 Format)Phase I study of NBTXR3 activated by radiotherapy in patients with advanced cancers treated with an anti-PD-1 therapy (Video MP4 Format)Phase I study of proton therapy in adjuvant pancreatic cancer (PROTON-PANC) (Video MP4 Format)Phase I study of regorafenib in combination with vincristine and irinotecan in pediatric patients with recurrent or refractory solid tumors (Video MP4 Format)Phase I study of regorafenib in combination with vincristine and irinotecan in pediatric patients with recurrent or refractory solid tumors (PDF Format)Phase I study of rucaparib and irinotecan in advanced solid tumors with homologous recombination deficiency (HRD) mutations (PDF Format)Phase I study of SEA-CD40, gemcitabine, nab-paclitaxel, and pembrolizumab in patients with metastatic (Video MP4 Format)Phase I study of tazemetostat, an enhancer of zeste homolog-2 inhibitor, in pediatric pts with relapsed (Video MP4 Format)Phase I study of teclistamab, a humanized B-cell maturation antigen (BCMA) x CD3 bispecific antibody (Video MP4 Format)Phase I study of teclistamab, a humanized B-cell maturation antigen (BCMA) x CD3 bispecific antibody (PDF Format)Phase I study of the Bcl-2 inhibitor venetoclax with DA-EPOCH-R as initial therapy for aggressive B-cell lymphomas (Video MP4 Format)Phase I study of the Bcl-2 inhibitor venetoclax with DA-EPOCH-R as initial therapy for aggressive B-cell lymphomas (PDF Format)Phase I study results of APG-115, a MDM2-p53 antagonist in Chinese patients with advanced liposarcoma and other solid tumors (Video MP4 Format)Phase I trial of lorlatinib in patients with ALK-driven refractory or relapsed neuroblastoma (Video MP4 Format)Phase I trial of lorlatinib in patients with ALK-driven refractory or relapsed neuroblastoma (PDF Format)Phase Ib clinical study of CBP501, cisplatin, and nivolumab administered every three weeks in patients with advanced refractory tumors (Video MP4 Format)Phase Ib dose escalation and cohort expansion study of the novel myeloid differentiating agent MTL-CEBPA (Video MP4 Format)Phase Ib II neoadjuvant (N-) pembrolizumab (P) and chemotherapy for locally advanced urothelial cancer (laUC) (Video MP4 Format)Phase Ib II study of the IDH1-mutant inhibitor ivosidenib with the BCL2 inhibitor venetoclax + – azacitidine (Video MP4 Format)Phase Ib II study of the IDH1-mutant inhibitor ivosidenib with the BCL2 inhibitor venetoclax + – azacitidine (PDF Format)Phase Ib II trial of tisotumab vedotin (TV) ñ bevacizumab (BEV), pembrolizumab (PEM), or carboplatin (CBP) in recurrent (Video MP4 Format)Phase Ib study of a novel bivalent IAP antagonist APG-1387 in combination of pembrolizumab for patients (Video MP4 Format)Phase Ib study of BI 836880, a VEGF Ang2-blocking nanobody, in combination with BI 754091, an anti-PD-1 antibody (Video MP4 Format)Phase Ib study of CPX-351 lower-intensity therapy (LIT) plus venetoclax as first-line treatment for patients (Video MP4 Format)Phase Ib trial combining rapid determination of drug-drug interaction (DDI) followed by a dose finding period to assess safety (Video MP4 Format)Phase II III study of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients (Video MP4 Format)Phase II III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin (Video MP4 Format)Phase II III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin (PDF Format)Phase II neoadjuvant (N-) gemcitabine (G) and pembrolizumab (P) for locally advanced urothelial cancer (laUC) (Video MP4 Format)Phase II preoperative window study of SAR439859 versus letrozole in post-menopausal women with newly diagnosed (Video MP4 Format)Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) (Video MP4 Format)Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) (PDF Format)Phase II randomized trial of carboplatin + pemetrexed + bevacizumab, + – atezolizumab in stage IV non-squamous (Video MP4 Format)Phase II study assessing tolerability, efficacy, and biomarkers for durvalumab (D) ñ tremelimumab (T) and gemcitabine (Video MP4 Format)Phase II study of alisertib as a single agent in recurrent or progressive atypical teratoid rhabdoid tumors (Video MP4 Format)Phase II study of antidisialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma (AOST1421) (Video MP4 Format)Phase II study of antidisialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma (AOST1421) (PDF Format)Phase II study of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC) (Video MP4 Format)Phase II study of copanlisib in patients with tumors with PIK3CA mutations (PTEN loss allowed) NCI MATCH EAY131-Z1F (PDF Format)Phase II study of gedatolisib for small-cell lung cancer (SCLC) patients (pts) with genetic alterations in PI3K AKT mTOR pathway (Video MP4 Format)Phase II study of nivolumab and ipilimumab for advanced rare genitourinary cancers (Video MP4 Format)Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-na‹ve patients (pts) with advanced renal (Video MP4 Format)Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-na‹ve patients (pts) with advanced renal (PDF Format)Phase II study of pembrolizumab (pembro) plus platinum doublet chemotherapy and radiotherapy as first-line therapy (Video MP4 Format)Phase II study of pembrolizumab (pembro) plus platinum doublet chemotherapy and radiotherapy as first-line therapy (PDF Format)Phase II study of pembrolizumab plus olaparib in the treatment of patients with advanced cholangiocarcinoma (Video MP4 Format)Phase II study of pevonedistat (P) + azacitidine (A) versus A in patients (pts) with higher-risk myelodysplastic syndromes (MDS) (Video MP4 Format)Phase II study of pevonedistat (P) + azacitidine (A) versus A in patients (pts) with higher-risk myelodysplastic syndromes (MDS) (PDF Format)Phase II study of savolitinib in patients (pts) with pulmonary sarcomatoid carcinoma (PSC) and other types of non-small cell (Video MP4 Format)Phase II study of the oral HIF-2à inhibitor MK-6482 for Von Hippel-Lindau disease-associated renal cell carcinoma (Video MP4 Format)Phase II study of the oral HIF-2à inhibitor MK-6482 for Von Hippel-Lindau disease-associated renal cell carcinoma (PDF Format)Phase II trial of durvalumab plus tremelimumab with concurrent radiotherapy as bladder-sparing therapy in patients (Video MP4 Format)Phase II trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for disease progression after PD-1 PD-L1 immune (Video MP4 Format)Phase II trial of lenvatinib (LEN) plus pembrolizumab (PEMBRO) for disease progression after PD-1 PD-L1 immune (PDF Format)Phase II trial of SAR439859 vs endocrine monotherapy in pre- and post-menopausal, estrogen receptor-positive (ER+) (Video MP4 Format)Phase II, multicenter trial of nivolumab (Nivo) and brentuximab vedotin (BV) in patients (Pts) with untreated Hodgkin lymphoma (HL) (Video MP4 Format)Phase II, open-label, randomized study of first-line zolbetuximab plus gemcitabine and nab-paclitaxel (GN) (Video MP4 Format)Phase III randomized controlled trial of eRAPID (electronic patient self-Reporting of Adverse-events Patient Information and advice) (Video MP4 Format)Phase III randomized controlled trial of eRAPID (electronic patient self-Reporting of Adverse-events Patient Information and advice) (PDF Format)Phase III study of first-line zolbetuximab + CAPOX versus placebo + CAPOX in Claudin 18.2+ HER2-advanced (Video MP4 Format)Phase III study of tislelizumab plus chemotherapy vs chemotherapy alone as first-line (1L) treatment for advanced squamous (Video MP4 Format)Phase III trial comparing antibody-drug conjugate (ADC) SAR408701 with docetaxel in patients with metastatic non-squamous (Video MP4 Format)Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative (Video MP4 Format)Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative (PDF Format)Phase III, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of adagloxad simolenin (Video MP4 Format)Quality and reliability of online video information of breast cancer in Spanish (Video MP4 Format)Quality of life (QOL) for the treatment sequence of abiraterone acetate plus prednisone (AAP) followed by enzalutamide (ENZ) (Video MP4 Format)Quality of life in patients with locally advanced head and neck cancer undergoing chemoradiation with once-a-week (Video MP4 Format)Quality of life of adults and children with TRK fusion cancer treated with larotrectinib compared to the general population (Video MP4 Format)Quality-adjusted time without symptoms or toxicity (Q-TWiST) of lenvatinib plus everolimus versus everolimus (Video MP4 Format)Radiation-induced changes in the inflammatory microenvironment composition of lung cancer brain metastases (Video MP4 Format)Radiographic paradoxical response in patients with metastatic castrate-resistant prostate cancer (mCRPC) (Video MP4 Format)Radiotherapy after esophageal cancer stenting (ROCS) A pragmatic randomized controlled trial evaluating (Video MP4 Format)Radium-223 (Rad) and niraparib (Nira) treatment (tx) in castrate-resistant prostate cancer (CRPC) patients (pts) (Video MP4 Format)Ramucirumab in patients with advanced HCC and elevated alpha-fetoprotein (AFP) Outcomes by treatment-emergent ascites (Video MP4 Format)Randomized comparisons of bevacizumab (B) and irinotecan (I), added to temozolomide (T), in children with relapsed (Video MP4 Format)Randomized comparisons of bevacizumab (B) and irinotecan (I), added to temozolomide (T), in children with relapsed (PDF Format)Randomized phase II clinical trial of cisplatin carboplatin and etoposide (CE) alone or in combination with nivolumab (Video MP4 Format)Randomized phase II clinical trial of cisplatin carboplatin and etoposide (CE) alone or in combination with nivolumab (PDF Format)Randomized phase II study of axitinib versus observation in patients with recurred or metastatic adenoid cystic carcinoma (Video MP4 Format)Randomized phase II study of axitinib versus observation in patients with recurred or metastatic adenoid cystic carcinoma (PDF Format)Randomized phase II study of canakinumab (CAN) or pembrolizumab (PEM) as monotherapy or in combination (Video MP4 Format)Randomized phase II study of pembrolizumab (P) alone versus pegilodecakin (PEG) in combination with P as first-line (1L) (Video MP4 Format)Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with (Video MP4 Format)Randomized phase II study of sapanisertib (SAP) + paclitaxel (PAC) versus PAC alone in patients (pts) with advanced (Video MP4 Format)Randomized phase II study on gemcitabine with or without ramucirumab as second-line treatment for advanced (Video MP4 Format)Randomized phase II study on gemcitabine with or without ramucirumab as second-line treatment for advanced (PDF Format)Randomized phase II trial comparing the efficacy of standard-dose with high-dose twice-daily thoracic radiotherapy (TRT (Video MP4 Format)Randomized phase II trial comparing the efficacy of standard-dose with high-dose twice-daily thoracic radiotherapy (TRT (PDF Format)Randomized phase II trial of avelumab alone or with cetuximab for unresectable, locally advanced or metastatic (Video MP4 Format)Randomized phase II trial of MIBG versus MIBG vincristine irinotecan versus MIBG vorinostat for relapsed refractory neuroblastoma (Video MP4 Format)Randomized phase II trial of MIBG versus MIBG vincristine irinotecan versus MIBG vorinostat for relapsed refractory neuroblastoma (PDF Format)Randomized phase III study of high-dose methotrexate and whole brain radiotherapy with or without concomitant (Video MP4 Format)Randomized phase III study of high-dose methotrexate and whole brain radiotherapy with or without concomitant (PDF Format)Randomized phase III study of irinotecan cisplatin (IP) versus etoposide cisplatin (EP) for completely resected high-grade (Video MP4 Format)Randomized phase III study of irinotecan cisplatin (IP) versus etoposide cisplatin (EP) for completely resected high-grade (PDF Format)Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer (Video MP4 Format)Randomized trial of a collaborative palliative and oncology care intervention to improve communication (Video MP4 Format)Randomized trial of a perioperative geriatric intervention for older adults with cancer (Video MP4 Format)Randomized trial of a perioperative geriatric intervention for older adults with cancer (PDF Format)Randomized trial of a symptom monitoring intervention for hospitalized patients with advanced cancer (NCT03396510) (Video MP4 Format)Randomized trial of web-based genetic education versus usual care in advanced cancer patients undergoing (Video MP4 Format)Randomized trial of web-based genetic education versus usual care in advanced cancer patients undergoing (PDF Format)Ranking of therapeutic regimens for hormone receptor-positive, HER2-negative, metastatic breast cancer (MBC) (Video MP4 Format)Rapid expansion of M-MDSCs and association with high levels of plasma TSLP and primary resistance to PD-1 (Video MP4 Format)Rare Variant Histologies in Renal Cell Carcinoma Making the Unclear Be More Clear (Video MP4 Format)Rare Variant Histologies in Renal Cell Carcinoma Making the Unclear Be More Clear (PDF Format)Real-world clinical effectiveness and safety of olaparib monotherapy in HER2-negative gBRCA-mutated metastatic (Video MP4 Format)Real-world outcomes of advanced melanoma patients not represented in phase III trials (Video MP4 Format)Real-world patterns of treatment and recurrence by frailty status among older women with HR-positive (Video MP4 Format)Real-world performance of blood-based host immune profiling in first-line immunotherapy treatment in advanced-stage (Video MP4 Format)Real-world survey of pneumonitis radiation pneumonitis among patients with locally advanced non-small cell lung cancer (Video MP4 Format)Reassessing PI3K Inhibitors in Indolent Lymphomas (Video MP4 Format)Recurrent Meningioma Are We Ready for Precision Medicine (PDF Format)Rechallenging with immune checkpoint inhibition after a treatment-limiting immune-related adverse event (Video MP4 Format)Redefining Cervical Cancer Treatment (Video MP4 Format)Refining the Understanding of Immune Checkpoint Blockade in Soft Tissue Sarcoma (Video MP4 Format)Refining the Use of Immunotherapy in Advanced Triple-Negative Breast Cancer (Video MP4 Format)Refining the Use of Immunotherapy in Advanced Triple-Negative Breast Cancer (PDF Format)Reflection rounds to facilitate resilience in hematology medical oncology fellows (Video MP4 Format)Registrational dataset from the phase I II ARROW trial of pralsetinib (BLU-667) in patients (pts) with advanced (Video MP4 Format)Relapsed Aggressive B-cell Lymphoma Be Careful Changing Lanes (Video MP4 Format)Relapsed Aggressive B-cell Lymphoma Be Careful Changing Lanes (PDF Format)Relationship between caregiver burden and psychological distress among stem cell transplant (SCT) recipients prior to transplant (Video MP4 Format)Relationship of infusion duration to safety, efficacy, and pharmacodynamics (PD) Second part of a phase I-II study (Video MP4 Format)Relationships among skeletal muscle, symptom burden, health care use, and survival in hospitalized patients with advanced cancer (Video MP4 Format)Relationships among skeletal muscle, symptom burden, health care use, and survival in hospitalized patients with advanced cancer (PDF Format)RELAY study of erlotinib (ERL) + ramucirumab (RAM) or placebo (PL) in EGFR-mutated metastatic non-small cell (Video MP4 Format)RELAY+ Exploratory study of ramucirumab plus gefitinib in untreated patients (pts) with epidermal growth factor receptor (EGFR) (Video MP4 Format)Reliability and correlations among quality measures for lung, breast, and colorectal cancer (Video MP4 Format)RE-MIND study A propensity score-based 1 1 matched comparison of tafasitamab + lenalidomide (L-MIND) versus (Video MP4 Format)Repurposing Novel Agents for Sarcoma Therapy (Video MP4 Format)Repurposing Novel Agents for Sarcoma Therapy (PDF Format)RESILIENT part I, an open-label, safety run-in of liposomal irinotecan in adults with small cell lung cancer (SCLC) (Video MP4 Format)RESILIENT part II an open-label, randomized, phase III study of liposomal irinotecan injection in patients (Video MP4 Format)Resource and reimbursement barriers to comprehensive cancer care (CCC) delivery An Association of Community (Video MP4 Format)Response criteria for intratumoral immunotherapy in solid tumors ItRECIST (Video MP4 Format)Response to immune checkpoint inhibitor (ICI) rechallenge after high-grade immune related adverse events (irAE) in patients (pts) (Video MP4 Format)Response to neoadjuvant chemotherapy and the 21-gene breast recurrence score in young women with estrogen (Video MP4 Format)Results from a phase I, open-label study of ceralasertib (AZD6738), a novel DNA damage repair agent, in combination (Video MP4 Format)Results from a phase I, open-label study of ceralasertib (AZD6738), a novel DNA damage repair agent, in combination (PDF Format)Results from a phase II study of bevacizumab and erlotinib in subjects with advanced hereditary leiomyomatosis (Video MP4 Format)Results from a phase II study of bevacizumab and erlotinib in subjects with advanced hereditary leiomyomatosis (PDF Format)Results from MAGENTA A national randomized four-arm noninferiority trial evaluating pre- and post-test genetic (Video MP4 Format)Results from MAGENTA A national randomized four-arm noninferiority trial evaluating pre- and post-test genetic (PDF Format)Results of a prospective phase II national study Prophylactic radical fimbriectomy (NCT01608074) (Video MP4 Format)Results of a phase II randomized trial of cisplatin + – veliparib in metastatic triple-negative breast cancer (TNBC) (Video MP4 Format)Results of a phase II trial of intense androgen deprivation therapy prior to radical prostatectomy (RP) in men (Video MP4 Format)Results of a phase II trial of intense androgen deprivation therapy prior to radical prostatectomy (RP) in men (PDF Format)Results of a randomized phase II III study comparing perioperative adriamycin plus ifosfamide and gemcitabine plus (Video MP4 Format)Results of a randomized phase II III study comparing perioperative adriamycin plus ifosfamide and gemcitabine plus (PDF Format)Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) (Video MP4 Format)Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) (PDF Format)Results of a randomized, open-label, multicenter trial to assess the safety, dose, and schedule ofRRx-001(001) (Video MP4 Format)Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC (Video MP4 Format)Results of crossover phase II component of randomized placebo-controlled trial evaluating oral THC (PDF Format)Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy (Video MP4 Format)Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy (PDF Format)Retreatment (reTx) of patients (pts) with refractory large B-cell lymphoma with axicabtagene ciloleucel (axi-cel) in ZUMA-1 (Video MP4 Format)Rhabdomyosarcoma of the female genital tract Long-term outcome and association with DICER1 variation (Video MP4 Format)Rise of the Machines AI in Predicting Immunotherapy Outcomes (Video MP4 Format)Rise of the Machines AI in Predicting Immunotherapy Outcomes (PDF Format)Risk of chronic opioid use after radiation for head and neck cancer A systematic review and meta-analysis (Video MP4 Format)Risk of secondary hematologic malignancies in patients with ovarian cancer treated with PARP inhibitors (Video MP4 Format)Role of adjuvant imatinib dose in radically resected GIST harboring KIT exon 9 mutations (Video MP4 Format)Role of high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma (Video MP4 Format)ROMAN Reduction in oral mucositis with avasopasem manganese (GC4419)-phase III trial in patients (Video MP4 Format)RTOG 3506 (STEEL) A study of salvage radiotherapy with or without enzalutamide in recurrent prostate cancer following surgery (Video MP4 Format)Sacituzumab govitecan (SG) in patients (pts) with previously treated metastatic endometrial cancer (mEC) (Video MP4 Format)Safety and activity of autologous T cells with enhanced NY-ESO-1-specific T-cell receptor (GSK3377794) (Video MP4 Format)Safety and clinical activity of atezolizumab (atezo) + radium-223 dichloride (r-223) in 2L metastatic castration-resistant (Video MP4 Format)Safety and clinical activity of gene-engineered T-cell therapy targeting HPV-16 E7 for epithelial cancers (Video MP4 Format)Safety and clinical activity of gene-engineered T-cell therapy targeting HPV-16 E7 for epithelial cancers (PDF Format)Safety and efficacy of biweekly gemcitabine in combination with capecitabine (GemCap) in elderly and frail patients (pts) (Video MP4 Format)Safety and efficacy of gemtuzumab ozogamicin and venetoclax in patients with relapsed or refractory CD33+ (Video MP4 Format)Safety and efficacy of neoadjuvant intravesical oncolytic MV-NIS in patients undergoing radical cystectomy (RC) (Video MP4 Format)Safety and efficacy of pemigatinib plus pembrolizumab combination therapy in patients (pts) with advanced malignancies (Video MP4 Format)Safety and efficacy of tazemetostat, an enhancer of zeste-homolog 2 inhibitor, in patients with relapsed (Video MP4 Format)Safety and overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) (Video MP4 Format)Safety and preliminary clinical activity of the MET antibody mixture, Sym015 in advanced non-small cell lung cancer (NSCLC) (Video MP4 Format)Safety and preliminary clinical activity of the MET antibody mixture, Sym015 in advanced non-small cell lung cancer (NSCLC) (PDF Format)Safety and preliminary efficacy of rogaratinib in combination with atezolizumab in a phase Ib II study (FORT-2) of first-line (Video MP4 Format)Safety and tolerability of MEDI0562 in combination with durvalumab or tremelimumab in patients with advanced solid tumors (PDF Format)Safety of acalabrutinib (Acala) monotherapy in hematologic malignancies Pooled analysis from clinical trials (Video MP4 Format)Safety outcomes of darolutamide versus apalutamide and enzalutamide in nonmetastatic castration-resistant prostate cancer (nmCRPC) (Video MP4 Format)Sarcoma – Sarcoma Highlights (Video MP4 Format)Sarcoma – Sarcoma Highlights (PDF Format)Saving the best to the last Can we wait for second-line (Video MP4 Format)SAVOIR A phase III study of savolitinib versus sunitinib in pts with MET-driven papillary renal cell carcinoma (PRCC) (Video MP4 Format)SAVOIR A phase III study of savolitinib versus sunitinib in pts with MET-driven papillary renal cell carcinoma (PRCC) (PDF Format)SBT6050, a HER2-directed TLR8 therapeutic, as a systemically administered, tumor-targeted human myeloid cell agonist (Video MP4 Format)Scalp cooling to prevent chemotherapy induced alopecia (CIA) in black patients Differences in efficacy (Video MP4 Format)Seek and Ye Shall Find Germline Mutations in Somatic Profiling (Video MP4 Format)Seek and Ye Shall Find Germline Mutations in Somatic Profiling (PDF Format)Segmental chromosome aberrations and clinical response impact outcome of inss stage III patients (Video MP4 Format)Segmental chromosome aberrations and clinical response impact outcome of inss stage III patients (PDF Format)Selinexor, daratumumab, and dexamethasone in patients with relapsed refractory multiple myeloma (MM) (Video MP4 Format)Selpercatinib (LOXO-292) in patients with RET-fusion+ non-small cell lung cancer (Video MP4 Format)Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer (Video MP4 Format)Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical (Video MP4 Format)Sequential chemoradiation versus radiation alone or concurrent chemoradiation in adjuvant treatment after radical (PDF Format)Sharpening the Approach on RET and ALK (Video MP4 Format)Sharpening the Approach on RET and ALK (PDF Format)Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer (Video MP4 Format)Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer (PDF Format)SIENDO ENGOT-EN5 A randomized phase III trial of maintenance with selinexor placebo after combination (Video MP4 Format)Significance of meflin-positive cancer-associated fibroblasts in predicting response to immune checkpoint inhibitors (Video MP4 Format)Significant antitumor activity for low-dose ipilimumab (IPI) with pembrolizumab (PEMBRO) immediately following progression (Video MP4 Format)Significant antitumor activity for low-dose ipilimumab (IPI) with pembrolizumab (PEMBRO) immediately following progression (PDF Format)Sintilimab in patients with advanced esophageal squamous cell carcinoma refractory to previous chemotherapy (Video MP4 Format)Single agent PD-1 inhibitor biomarkers in untreated and previously treated advanced RCC (Video MP4 Format)Single agent targeted agents vs combinations with IO what is the optimal future therapy in advanced Urothelial Cancer (Video MP4 Format)Single agent targeted agents vs combinations with IO what is the optimal future therapy in advanced Urothelial Cancer (PDF Format)Single cell mapping of human brain tumors reveals tumor-specific education of tissue-invading leukocytes (Video MP4 Format)Single vector multiplexed shRNA provides a non-gene edited strategy to concurrently knockdown the expression (Video MP4 Format)Single-center phase I Ib study of concurrent intrathecal (IT) and intravenous (IV) nivolumab (N) for metastatic melanoma (MM) (Video MP4 Format)Single-center phase I Ib study of concurrent intrathecal (IT) and intravenous (IV) nivolumab (N) for metastatic melanoma (MM) (PDF Format)Small Cell Lung Cancer Moving Toward Precision Oncology (Video MP4 Format)Small Cell Lung Cancer Moving Toward Precision Oncology (PDF Format)Small Molecule Monotherapy and Immuno-Oncology Combinatorial Targeting of Oncogenes and Oncogene (Video MP4 Format)Small Molecule Monotherapy and Immuno-Oncology Combinatorial Targeting of Oncogenes and Oncogene (PDF Format)Social media use among NCI designated cancer centers Where is the diversity (Video MP4 Format)Spatial analysis of tumor immune microenvironment (TIME) in patients treated with Bintrafusp alfa (Video MP4 Format)SPEARHEAD-1 A phase II trial of ADP-A2M4 SPEAR T cells in patients with advanced synovial sarcoma or myxoid round cell liposarcoma (Video MP4 Format)Spice Girls Spicing Up Novel Combination in Multiple Myeloma (Video MP4 Format)Spice It Up Immunotherapy for RAIR Thyroid Cancers (Video MP4 Format)Spice It Up Immunotherapy for RAIR Thyroid Cancers (PDF Format)Sporadic late-onset nemaline myopathy with monoclonal paraprotein as a malignancy rather than disimmunity (Video MP4 Format)Stability of rare TP53 co-mutations in AML patients (Video MP4 Format)STAG2-mutated AML patients ASXL1 cohesin binding motif status and mutation landscape (Video MP4 Format)Stamping Out Treatment Toxicities With Technology (Video MP4 Format)Stamping Out Treatment Toxicities With Technology (PDF Format)Statin treatment improves response to anti-PD1 agents in patients with malignant pleural mesothelioma (Video MP4 Format)Stay Sharp on PARP and More (Video MP4 Format)Stay Sharp on PARP and More (PDF Format)Student loan debt and visa status influence on career choices for hematology and medical oncology fellows in the United States (Video MP4 Format)Study EV-103 Durability results of enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma (Video MP4 Format)Study EV-103 New randomized cohort testing enfortumab vedotin as monotherapy or in combination with pembrolizumab (Video MP4 Format)Study of anlotinib combined with icotinib as the first-line treatment in non-small cell lung cancer (NSCLC) patients (Video MP4 Format)Streamlining the genetics pipeline to increase testing for patients at risk for hereditary prostate cancer (Video MP4 Format)Subcellular partitioning of Kaiso (ZBTB33) as a biomarker to predict overall breast cancer survival (Video MP4 Format)Successful tumor-infiltrating lymphocyte (TIL) growth from uveal melanoma (UM) using a three-signal (3.0) method (Video MP4 Format)Superior therapy response predictions for patients with glioblastoma (GBM) using Cellworks Singula MyCare-009-03 (Video MP4 Format)Superior therapy response predictions for patients with low-grade glioma (LGG) using Cellworks Singula MyCare-009-04 (Video MP4 Format)Surgery at primary and metastatic sites for stage IV breast cancer (BC) A National Cancer Database (NCDB) analysis (Video MP4 Format)Surgery for unresectable stage IIIC and IV melanoma in the era of new systemic therapy (Video MP4 Format)Surgical Options and Optional Surgery in Breast Cancer (Video MP4 Format)Surgical Options and Optional Surgery in Breast Cancer (PDF Format)Survival differences by race after minimally invasive versus open radical hysterectomy (Video MP4 Format)Survival impact of multidisciplinary thoracic oncology care in a regional healthcare system (Video MP4 Format)Survival outcome in patients with metastatic castration-resistant prostate cancer according to first-line treatment (Video MP4 Format)Survival outcomes among older adults (OA) receiving second-line therapy for metastatic CRC (mCRC) (Video MP4 Format)SWOG S1505 Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine nab-paclitaxel (Video MP4 Format)SWOG S1505 Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine nab-paclitaxel (PDF Format)Symptoms and Survivorship (Video MP4 Format)Symptoms and Survivorship (PDF Format)Systemic therapy for patients with breast cancer and one to three brain metastases (BM) (Video MP4 Format)Tackling the Unknown, Molecularly (Video MP4 Format)Tackling the Unknown, Molecularly (PDF Format)Tackling Treatment Resistance in ER+ Metastatic Breast Cancer (Video MP4 Format)Tackling Treatment Resistance in ER+ Metastatic Breast Cancer (PDF Format)Tailoring Neoadjuvant Treatment for Colon and Rectal Cancer (Video MP4 Format)Tailoring Neoadjuvant Treatment for Colon and Rectal Cancer (PDF Format)Tailoring Therapy for HER (Video MP4 Format)TALAPRO-2 a placebo-controlled phase III study of talazoparib (TALA) plus enzalutamide (ENZA) for patients (Video MP4 Format)Talk to Me Advancing Patient Care Through PROs (Video MP4 Format)Talk to Me Advancing Patient Care Through PROs (PDF Format)Targeted Interventions in Relapse Refractory Leukemias (Video MP4 Format)Targeted Oral Agents in Leukemia Testing Combinations and Modulating Dose Intensity (Video MP4 Format)Targeted Oral Agents in Leukemia Testing Combinations and Modulating Dose Intensity (PDF Format)Targeted therapy based on germline analysis of tumor-normal sequencing (MSK-IMPACT) in a pan-cancer population (Video MP4 Format)Targeting Anti-Apoptotic Proteins Combinations With Immuno-Oncology Agents and Mitigating Toxicities (Video MP4 Format)Targeting HER2 in combination with anti-PD-1 and chemotherapy confers a significant tumor shrinkage of gastric cancer (Video MP4 Format)Targeting the Immune Microenvironment (Video MP4 Format)Targeting the Immune Microenvironment (PDF Format)Targeting Upstream and Downstream Effectors in the PI3K Signaling Cascade (Video MP4 Format)Targeting Upstream and Downstream Effectors in the PI3K Signaling Cascade (PDF Format)TBCRC 048 A phase II study of olaparib monotherapy in metastatic breast cancer patients with germline or somatic (Video MP4 Format)TBCRC 048 A phase II study of olaparib monotherapy in metastatic breast cancer patients with germline or somatic (PDF Format)TCR clonality and Treg frequency as predictors of outcome in stage III NSCLC treated with durvalumab (Video MP4 Format)Technology-enabled longitudinal monitoring of patient-reported outcomes (PROs) to individualize care of immune-related (Video MP4 Format)Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence (Video MP4 Format)Temozolomide-induced hypermutation is associated with high-grade transformation, distant recurrence (PDF Format)Temsirolimus combined with etoposide and cyclophosphamide for relapsed refractory acute lymphoblastic leukemia (PDF Format)Time to central nervous system (CNS) metastases (mets) with atezolizumab (A) or placebo (P) combined (Video MP4 Format)Time to Reflect on What We Do Below the Peritoneal Reflection (Video MP4 Format)Time to Reflect on What We Do Below the Peritoneal Reflection (PDF Format)Timing of response to venetoclax combination treatment in older patients with acute myeloid leukemia (Video MP4 Format)Timing of US Food and Drug Administration (FDA) cancer drug approvals relative to publication of clinical trial results (Video MP4 Format)Tisagenlecleucel (Tisa) for relapsed refractory (r r) acute lymphoblastic leukemia (ALL) (Video MP4 Format)TIVO-3 Final OS analysis of a phase III, randomized, controlled, multicenter, open-label study to compare (Video MP4 Format)TLC Renal Insufficiency in Multiple Myeloma-Don’t Go Chasing Waterfalls (Video MP4 Format)TLC Renal Insufficiency in Multiple Myeloma-Don’t Go Chasing Waterfalls (PDF Format)To ERr Is Human; to Predict, Divine (Video MP4 Format)To Everything There Is a Season A Time to De-Escalate (Video MP4 Format)To Everything There Is a Season A Time to De-Escalate (PDF Format)To Everything There Is a Season A Time to Escalate (Video MP4 Format)To Everything There Is a Season A Time to Escalate (PDF Format)To Guide or Not to Guide (Video MP4 Format)To Guide or Not to Guide (PDF Format)To the Heart of the Matter Understanding and Improving Cardiovascular Health in Cancer (Video MP4 Format)To the Heart of the Matter Understanding and Improving Cardiovascular Health in Cancer (PDF Format)Tolerability and durable respones of the PI3Kë inhibitor ME-401 administered on an intermittent schedule in relapsed (Video MP4 Format)Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in MDS and AML patients (Video MP4 Format)Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in MDS and AML patients (PDF Format)Tolerability and preliminary efficacy of BXQ-350 for refractory solid tumors and high-grade gliomas (Video MP4 Format)Tolerability and preliminary efficacy of BXQ-350 for refractory solid tumors and high-grade gliomas (PDF Format)TOOme A novel computational framework to infer cancer tissue-of-origin by integrating both gene mutation and expression (Video MP4 Format)Total mesorectal excision compared to local excision in locally advanced rectal cancer achieving complete pathological (Video MP4 Format)Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer (Video MP4 Format)Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer (PDF Format)TPExtreme randomized trial Quality of Life (QoL) and survival according to second-line treatments in patients (Video MP4 Format)TPExtreme randomized trial Quality of Life (QoL) and survival according to second-line treatments in patients (PDF Format)Tucatinib versus placebo added to trastuzumab and capecitabine for patients with previously treated HER2+ metastatic (Video MP4 Format)Tucatinib versus placebo added to trastuzumab and capecitabine for patients with previously treated HER2+ metastatic (PDF Format)Tumor antigen expression and survival of patients with previously treated advanced non-small cell lung cancer (NSCLC) (Video MP4 Format)Tumor detection rates in screening carriers with SDHx-related hereditary paraganglioma-pheochromocytoma (Video MP4 Format)Tumor microenvironment associated with increased pretreatment density of activated PD-1+ LAG-3+ – TIM-3- CD8+ T cells (Video MP4 Format)Tumor mutational load, microsatellite instability and actionable mutations in metastatic colorectal cancer (Video MP4 Format)Tumor normal genomic profiling in patients with metastatic solid tumors identifies pathogenic germline variants (Video MP4 Format)Tumor normal genomic profiling in patients with metastatic solid tumors identifies pathogenic germline variants (PDF Format)Tumor, immune, and stromal characteristics associated with clinical outcomes with atezolizumab (atezo) (Video MP4 Format)Tumor, immune, and stromal characteristics associated with clinical outcomes with atezolizumab (atezo) (PDF Format)Tumor-informed assessment of molecular residual disease and its incorporation into practice for patients (Video MP4 Format)Tumor-Intrinsic Factors and Immunotherapy Response The Known and Unknown (Video MP4 Format)Tumor-Intrinsic Factors and Immunotherapy Response The Known and Unknown (PDF Format)Tumor-Specific Vaccines Lessons Learned from HPV (Video MP4 Format)Tumor-Specific Vaccines Lessons Learned from HPV (PDF Format)Tweets, Likes, and Posts Harnessing the Power of Social Media (Video MP4 Format)Tweets, Likes, and Posts Harnessing the Power of Social Media (PDF Format)Twenty-four months RFS and updated toxicity data from OpACIN-neo A study to identify the optimal dosing (Video MP4 Format)Type of prior genotoxic insult determines the genomic characteristics of therapy-related acute myeloid leukemia (Video MP4 Format)The anti-PD-1 antibody spartalizumab in combination with dabrafenib and trametinib in advanced BRAF V600-mutant melanoma (Video MP4 Format)The association between drug industry payments and NCCN guideline panel membership (Video MP4 Format)The association between immune-related adverse events and efficacy outcomes with consolidation pembrolizumab (Video MP4 Format)The association of molecular biomarkers with efficacy of pembrolizumab versus paclitaxel in patients with gastric cancer (Video MP4 Format)The BRCA founder outreach study Initial results of a digital health model (Video MP4 Format)The BRCA founder outreach study Initial results of a digital health model (PDF Format)The comprehensive methylation landscape of metastatic castration-resistant prostate cancer (mCRPC) identifies new phenotypic subtypes (Video MP4 Format)The contribution of clinical subtype to survival differences among patients with de novo and recurrent metastatic (Video MP4 Format)The correlation between clinical benefit and financial cost of cancer drugs (Video MP4 Format)The Challenge of Defining a Benchmark for Single-Arm Trials of Combination Therapy in Advanced Sarcoma (Video MP4 Format)The Challenge of Defining a Benchmark for Single-Arm Trials of Combination Therapy in Advanced Sarcoma (PDF Format)The development and validation of a novel targeted methylation sequencing technology detecting 0.003 percent (Video MP4 Format)The economic impact of cancer-related premature mortality in Brazil A human capital approach analysis (Video MP4 Format)The effect of longitudinal exercise programming in breast cancer patients (Video MP4 Format)The effect of neutropenia on patient-reported functioning and quality of life (QOL) among palbociclib participants (Video MP4 Format)The FLEX real-world data platform explores new gene expression profiles and investigator-initiated protocols in early stage breast cancer (Video MP4 Format)The impact of adjuvant therapy for non-metastatic thymic carcinoma An analysis of the surveillance, epidemiology (Video MP4 Format)The impact of BRAF mutation status on clinical outcomes with single-agent PD-1 inhibitor versus combination ipilimumab nivolumab (Video MP4 Format)The impact of pattern of tumor response and other post-treatment histologic features on local recurrence (Video MP4 Format)The impact of poly ADP ribose polymerase (PARP) inhibitors on clonal hematopoiesis (Video MP4 Format)The impact of residual metabolic primary tumor volume after completion of thoracic irradiation in patients (Video MP4 Format)The impact of tobacco retail density on overall survival (OS) in lung cancer survivors (Video MP4 Format)The impact of tumor NGS testing on hereditary cancer risk assessment and population management (Video MP4 Format)The IMPemBra trial, a phase II study comparing pembrolizumab with intermittent short-term dual MAPK pathway (Video MP4 Format)The landscape of genomic alterations detected in serial circulating tumor DNA (ctDNA) in clinical progressive (Video MP4 Format)The Mixed Bag Biomarkers and Therapeutics to Advance the Treatment of ER+ Advanced Disease (Video MP4 Format)The nature and management of acquired resistance to PD1-based therapy in melanoma (Video MP4 Format)The next frontier IO combos for recurrent metastatic head and neck cancer (Video MP4 Format)The oncology hospital at home Health care utilization outcomes from the huntsman at home trial (Video MP4 Format)The oncology hospital at home Health care utilization outcomes from the huntsman at home trial (PDF Format)The pediatric precision oncology study INFORM Clinical outcome and benefit for molecular subgroups (Video MP4 Format)The pediatric precision oncology study INFORM Clinical outcome and benefit for molecular subgroups (PDF Format)The potential cost-effectiveness of a risk-based pancreatic cancer screening strategy in new-onset diabetes (Video MP4 Format)The preliminary efficacy and safety data of KN046 in patients failed on prior immune checkpoint inhibitors therapy (Video MP4 Format)The prevalence of HLA LOH across 10 cancer types in Chinese patients (Video MP4 Format)The prevalence of KRASG12C mutations utilizing circulating tumor DNA (ctDNA) in 80,911 patients with cancer (Video MP4 Format)The role of tumor markers for relapse detection in central nervous system non-germinomatous germ cell tumors (CNS-NGGCT) (Video MP4 Format)The role of tumor markers for relapse detection in central nervous system non-germinomatous germ cell tumors (CNS-NGGCT) (PDF Format)The safety and efficacy of weekly paclitaxel and cisplatin chemotherapy for patients with ovarian cancer (Video MP4 Format)The spatial localization of CD163+ tumor-associated macrophages predicts prognosis and response to therapy (Video MP4 Format)The Times They Are a-Changin Evolving Trial Design for Early Breast Cancer (Video MP4 Format)TheraP A randomised phase II trial of 177Lu-PSMA-617 (LuPSMA) theranostic versus cabazitaxel in metastatic castration (Video MP4 Format)TheraP A randomised phase II trial of 177Lu-PSMA-617 (LuPSMA) theranostic versus cabazitaxel in metastatic castration (PDF Format)Therapeutic Approaches to Protein Degradation PROTACs and E3 Ligase Modulation (Video MP4 Format)Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS-mutated non-small cell lung cancer (NSCLC) (Video MP4 Format)Therapeutic vulnerabilities among KRAS G12C mutant (mut) advanced cancers based on co-alteration (co-alt) patterns (Video MP4 Format)Thoracic Cancers International COVID-19 Collaboration (TERAVOLT) Impact of type of cancer therapy (Video MP4 Format)Thoracic Cancers International COVID-19 Collaboration (TERAVOLT) Impact of type of cancer therapy (PDF Format)Three versus one year of adjuvant imatinib for high-risk gastrointestinal stromal tumor (GIST) (Video MP4 Format)Three versus one year of adjuvant imatinib for high-risk gastrointestinal stromal tumor (GIST) (PDF Format)Three versus six months of adjuvant chemotherapy for colorectal cancer A multi-country cost-effectiveness (Video MP4 Format)Three-year follow-up of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2-blockade (Video MP4 Format)Three-year follow-up of neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2-blockade (PDF Format)Three-year follow-up of treatment-na‹ve and previously treated patients with Waldenstr”m macroglobulinemia (WM) (Video MP4 Format)TRACC Tracking mutations in cell-free DNA to predict relapse in early colorectal cancer (Video MP4 Format)Trainee and workforce diversity in hematology and oncology Ten years later what has changed (Video MP4 Format)Trainee and workforce diversity in hematology and oncology Ten years later what has changed (PDF Format)Translational relevance of androgen receptor immunohistochemistry scoring systems for data harmonization (Video MP4 Format)Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable (Video MP4 Format)Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable (PDF Format)Trastuzumab deruxtecan (T-DXd; DS-8201) in combination with pembrolizumab in patient (Video MP4 Format)Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-mutated metastatic non-small cell lung cancer (NSCLC) (Video MP4 Format)Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-mutated metastatic non-small cell lung cancer (NSCLC) (PDF Format)Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-positive advanced gastric or gastroesophageal junction (Video MP4 Format)Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression NRG Oncology RTOG 1010 (Video MP4 Format)Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression NRG Oncology RTOG 1010 (PDF Format)Treatment effects (TEs) of EGFR monoclonal antibodies (mAbs) in metastatic colorectal cancer (mCRC) patients (pts) (Video MP4 Format)Treatment intensity and risk of chronic health conditions and late mortality among long-term survivors of Wilms tumor (Video MP4 Format)Trends in FDA cancer registration trial design over time, 1969-2020 (Video MP4 Format)Trial in progress A phase I II, open-label, dose-escalation, safety and tolerability study of NC318 in subjects (Video MP4 Format)Trial in progress A phase I study of AMG 199, a half-life extended bispecific T-cell engager (HLE BiTE) immune therapy (Video MP4 Format)Trial in progress A phase Ib study of AMG 510, a specific and irreversible KRASG12C inhibitor, in combination (Video MP4 Format)Trial in progress a phase II, multicenter, single-arm study of zanubrutinib (BGB-3111) in patients with previously treated (Video MP4 Format)Trial in progress Neoadjuvant immune checkpoint blockade in resectable malignant pleural mesothelioma (Video MP4 Format)TRIDENT-1 A global, multicenter, open-label Phase II study investigating the activity of repotrectinib in advanced solid (Video MP4 Format)TROPiCS-03 A phase II open-label study of sacituzumab govitecan (SG) in patients with metastatic solid tumors (Video MP4 Format)U.S. trends and racial ethnic disparities in opioid access among patients with poor prognosis cancer at the end of life (EOL) (Video MP4 Format)U.S. trends and racial ethnic disparities in opioid access among patients with poor prognosis cancer at the end of life (EOL) (PDF Format)Ultrasensitive multiplex detection of structural rearrangements in ALK, RET, ROS1 and PD-L1 using a comprehensive (Video MP4 Format)Unanticipated Consequences Finding Germline Variants Through Somatic Profiling (Video MP4 Format)Underdiagnosis and undertreament of modifiable cardiovascular risk factors A Childhood Cancer Survivor Study (CCSS) report (Video MP4 Format)Underdiagnosis and undertreament of modifiable cardiovascular risk factors A Childhood Cancer Survivor Study (CCSS) report (PDF Format)Understanding and predicting fatigue, cardiovascular (CV) decline & events after breast cancer treatment (UPBEAT) (Video MP4 Format)UnTIL We Meet Again Immune Biomarkers in Early-Stage Disease (Video MP4 Format)UnTIL We Meet Again Immune Biomarkers in Early-Stage Disease (PDF Format)Update of CARTITUDE-1 A phase Ib II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy (Video MP4 Format)Update of CARTITUDE-1 A phase Ib II study of JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy (PDF Format)Update on overall survival in COLUMBUS A randomized phase III trial of encorafenib (ENCO) plus binimetinib (BINI) (Video MP4 Format)Updated analysis of the inducible T-cell co-stimulatory receptor (ICOS) agonist, GSK3359609 (GSK609) (Video MP4 Format)Updated entrectinib data in children and adolescents with recurrent or refractory solid tumors, including primary CNS tumors (Video MP4 Format)Updated entrectinib data in children and adolescents with recurrent or refractory solid tumors, including primary CNS tumors (PDF Format)Updated overall survival (OS) and safety data from the randomized, phase III ALEX study of alectinib (ALC) versus (Video MP4 Format)Updated results from phase I dose-escalation study of AMG 330, a bispecific T-cell engager molecule, in patients (Video MP4 Format)Updated results from phase I dose-escalation study of AMG 330, a bispecific T-cell engager molecule, in patients (PDF Format)Updated results from the phase IIIb complement-1 study of ribociclib (RIB) plus letrozole (LET) in the treatment of HR+ (Video MP4 Format)Updates from a phase Ib study of isatuximab (Isa), bortezomib (V) and dexamethasone (D) plus cyclophosphamide (C) (Video MP4 Format)Upfront DPYD genotyping and toxicity associated with fluoropyrimidine-based concurrent chemoradiotherapy (Video MP4 Format)Uptake of oophorectomy in women with findings on multigene panel testing (Video MP4 Format)Uptake of oophorectomy in women with findings on multigene panel testing (PDF Format)Use of immune checkpoint inhibitors (ICIs) after prior ICI in metastatic renal cell carcinoma (mRCC) (Video MP4 Format)Use of real-world data to understand barriers to interventional clinical trial enrollment in community oncology clinics (COC) (Video MP4 Format)Use of simulation for training family caregivers of patients receiving radiation therapy (Video MP4 Format)Ushering Novel and Nontransplant Immune Therapies in Acute Leukemias (Video MP4 Format)Ushering Novel and Nontransplant Immune Therapies in Acute Leukemias (PDF Format)Using Genomics to Select for Checkpoint Blockade (Video MP4 Format)Using Genomics to Select for Checkpoint Blockade (PDF Format)Using machine learning to predict immunotherapy response in advanced melanoma (Video MP4 Format)Using machine learning to predict immunotherapy response in advanced melanoma (PDF Format)Using sequential next-generation sequencing assays to identify germline cancer predisposition variants (Video MP4 Format)Uterine Serous Cancer Expanding Targets (PDF Format)Utility of circulating cell-free DNA (cfDNA) analysis in patients with carcinoma of unknown primary (CUP) (Video MP4 Format)Utility of circulating cell-free DNA (cfDNA) analysis in patients with carcinoma of unknown primary (CUP) (PDF Format)Utilization of adjuvant chemotherapy in ‘ideal candidates’ with stage III colon cancer (Video MP4 Format)Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA (Video MP4 Format)Utilizing phenotypic characteristics of metastatic brain tumors to predict the probability of circulating tumor DNA (PDF Format)Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy (Video MP4 Format)Validation of nomograms to predict non-sentinel lymph node metastasis after positive sentinel lymph node in breast (Video MP4 Format)Validity of patient-reported outcomes to describe the symptom experience of patients enrolled on phase I clinical trials (Video MP4 Format)VCAN accumulation and proteolysis as predictors of T lymphocyte-excluded and permissive tumor microenvironments (Video MP4 Format)Veliparib (V) monotherapy (monoTx) following combination therapy with V + carboplatin paclitaxel (CP) in patients (Video MP4 Format)Veliparib (V) monotherapy after progression on placebo (PL) + carboplatin paclitaxel (CP) in patients (Video MP4 Format)Venous thromboembolism prophylaxis in ambulatory cancer patients initiating chemotherapy A cost-effectiveness analysis (Video MP4 Format)Video conference intervention for distance caregivers (DCGs) of patients with cancer Improving psychological outcomes (Video MP4 Format)Video vs in-person genetic counseling for men considering germline prostate cancer testing A patient-choice study (Video MP4 Format)Vismodegib (V) for organ preservation for locally advanced (LA) orbital periocular basal cell carcinoma (BCC) (Video MP4 Format)Vorasidenib (VOR; AG-881), an inhibitor of mutant IDH1 and IDH2, in patients (pts) with recurrent progressive glioma (Video MP4 Format)Vorasidenib (VOR; AG-881), an inhibitor of mutant IDH1 and IDH2, in patients (pts) with recurrent progressive glioma (PDF Format)Weekly selinexor, bortezomib, and dexamethasone (SVd) versus twice weekly bortezomib and dexamethasone (Vd) (Video MP4 Format)Weekly selinexor, bortezomib, and dexamethasone (SVd) versus twice weekly bortezomib and dexamethasone (Vd) (PDF Format)Welcome and Introduction of Howard A. Burris, III, MD, FACP, FASCO (Video MP4 Format)What’s Enough Regulatory Considerations (Video MP4 Format)What’s Enough Regulatory Considerations (PDF Format)Who Goes First The Optimal Timing of Surgical Intervention in Operable Pancreas Cancer (Video MP4 Format)Who Goes First The Optimal Timing of Surgical Intervention in Operable Pancreas Cancer (PDF Format)Whole transcriptome changes correlate to exceptional ovarian cancer responders A sub-analysis of a HIPEC Phase I trial (Video MP4 Format)Window-of-opportunity trial of nivolumab with or without the IDO inhibitor BMS-986205 in patients with resectable (Video MP4 Format)X versus XELOX versus PF in definitive concurrent chemoradiotherapy (DCRT) for local advanced squamous esophageal cancer (ESCC) (Video MP4 Format)You Gotta Treat HER Right (Video MP4 Format)You Gotta Treat HER Right (PDF Format)